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I. Lay Summary  
This study is split into two sections. Both sections explore the experiences of men 
who use illegal drugs. It explored the relationship between mindfulness and drug use. 
Mindfulness can be described as someone's ability to bring attention and awareness to the 
present moment in an impartial way. For example, when you are paying attention to what 
you're doing and not getting caught up in thinking about other things. Mindfulness skills can 
be developed in many ways, including mindful breathing exercises. These are when 
someone focuses all their attention on the breath. They may notice their thoughts but do 
not get caught up in them. They then try to focus the attention back on the breath. Research 
suggests that increasing a drug user's mindfulness can reduce their drug use and cravings 
and improve their mood and quality of life.  
The first part of the thesis looked at previous research on how well mindfulness-
based treatments reduced drug use. A detailed search of studies was made. The search 
included research that was written in English and had been checked by other researchers. 
We were only interested in seeing how well mindfulness works for male drug users. So, any 
research with female or mixed male and female participants were ignored. The studies we 
were interested in randomly split their participants into two groups. One group were given a 
treatment using mindfulness, and the other group received no treatment at all. After the 
treatment was finished, the groups were compared. It was thought that the group who 
received a mindfulness treatment might use fewer drugs or had fewer cravings than those 
who had not received the treatment.  A second researcher checked the list of studies to 
make sure the search was done correctly. Any differences of opinion were discussed until we 
agreed on the final list of studies. When we looked through all the studies, we found that all 
of them showed that the treatments reduced men's drug use and their cravings for the 
drugs. However, there were lots of differences in how effective the treatments were. This 
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could be because the studies were done in different ways, which may have led to different 
findings. For example, different types of mindfulness treatments were used in the studies. 
Also, the people in the studies used different types of drugs, and some research has shown 
this can affect the results. The review suggested that more research is needed to better 
understand how well these treatments work. 
The second part of the study was a survey that collected data to explore the 
relationships between mindfulness, shame, and stress. These are all thought to be important 
in men who struggle to stop their drug use. Shame is an emotion linked with feelings of low 
self-esteem. Research has found that feelings of shame and stress are common in men who 
take drugs. People often struggle with shame and stress because of difficult life experiences. 
These can include being rejected by others and abuse. Shame is also related to lower levels 
of sexual satisfaction and is also associated with some people’s need to use drugs. 
The survey recruited men who have sex with men (MSM). These men also take 
drugs to enjoy sex better. This type of drug use is called 'chemsex'. Some people have 
chemsex and it has a positive effect on their life. However, for some people, chemsex can 
lead to problems. Also, some MSM who enjoy chemsex find it difficult to have sex without 
drugs.   
To improve the study's design, experts by experience were involved in all stages of 
the process. The experts by experience for this study were men who have had chemsex, or 
they still do. They helped to get people involved in the project. They also helped to designing 
and explaining the results.  
There is not much research about treatments for chemsex. This section of the thesis 
explored the relationships between shame, stress, and mindfulness. This is to understand 
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better what sort of treatment might help people looking for support. Research suggests that 
increased mindfulness is related to lower levels of drug use. It is also related to higher levels 
of sexual satisfaction in men. This project hoped to explore the relationships between 
shame, sexual satisfaction, levels of distress and mindfulness in MSM who engage in 
chemsex. The experts by experience thought it was important to explore men's confidence 
in whether they can engage in sober sex. As there has been no research into confidence in 
MSM to engage in sober sex, it was agreed that this study should also explore this. However, 
these beliefs are very different for different behaviours, so a new questionnaire had to be 
designed for this study. This questionnaire measured a person's beliefs in whether they 
would be able to engage in sober sex.  
This project made these predictions:  
1) People who said that chemsex has a negative effect on their life will have higher 
levels of shame and stress. They would also say that they have lower levels of 
sexual satisfaction and confidence in being able to have sober sex. 
2) People who experience high levels of shame would have higher stress levels. 
They would also have lower sexual satisfaction and lower confidence in being 
able to have sober sex. 
3) People with higher levels of mindfulness would experience higher levels of 
sexual satisfaction and belief in being able to have sober sex. They would also 
have lower levels of shame and stress. 
4) There would be a relationship between shame and sexual satisfaction and 
shame and self-beliefs. These relationships would change depending on people's 
levels of mindfulness. 
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The survey results confirmed these predictions. People who felt that chemsex was 
having a negative effect on their lives had higher levels of shame and stress. They also had 
lower levels of mindfulness, sexual satisfaction, and confidence in being able to have sober 
sex. Higher levels of shame were related to lower levels of sexual satisfaction. They were 
related to people having lower confidence in having sober sex. Higher levels of shame were 
also associated with high levels of stress.  The research found that higher levels of 
mindfulness were related to increased sexual satisfaction and people's confidence in having 
sober sex. However, it also related to lower levels of shame and distress.  
The last question looked at the different parts of mindfulness. Mindfulness can be 
broken down into different parts. In this study mindfulness was broken down into five 
different types. 
• Observing or noticing experiences,  
• Describing or being able to talk or write about experiences,  
• Acting with awareness or being aware of what you are doing as you do it 
• Non-judgmental or not being critical about experiences, and 
• Nonreactivity or not getting caught up in experiences. 
The results showed that three of the five facets of mindfulness changed the relationship 
between shame and sexual satisfaction. These were observing, acting with awareness and 
nonreactivity. However, all the facets of mindfulness were shown to change the relationship 
between shame and people's confidence in having sober sex. This study suggests that it may 
be useful to develop mindfulness therapies for people struggling with chemsex. It suggests 
that some types of mindfulness might be more important than others. However, further 
research is needed to confirm this. 
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II. A Systematic Review examining the effectiveness of mindfulness-based 





There is an urgent need for effective therapies for men with problematic illicit substance 
use. This is particularly important amongst male users as prevalence rates are higher and 
support seeking behaviours are lower.  The evidence base for mindfulness interventions in 
treating substance misuse is growing. Systematic reviews investigating the effectiveness of 
mindfulness treatments indicate posttreatment reductions in substance cravings and 
relapse.  However, most research has been conducted on alcohol and tobacco using mixed-
gendered populations. Thus, this systematic review assessed the methodological 
characteristics and findings of studies evaluating mindfulness interventions for illegal drug 
misuse in male-only populations published by 2021. The review also includes the first meta-
analysis of randomised controlled trials of mindfulness interventions for illegal substance 
misuse in male-only populations. A search of three bibliographic databases (i.e., PubMed, 
PsycInfo, and Web of Science) identified potentially relevant studies. Abstract and full paper 
reviews of these studies further reduced the number of those meeting the inclusion and 
exclusion criteria. Meta-analytic results revealed significant small-to-large effects of 
mindfulness treatments in reducing substance cravings. However, this sample of studies 
demonstrated highly heterogeneous results. This heterogeneity was theorised to be caused 
by variations across the studies in methodological quality, the different types of mindfulness 
treatments being evaluated, and the range of drugs being treated. Despite this 
heterogeneity, this review supports the evidence base that suggests that mindfulness 
interventions are appropriate for men undergoing treatment for illegal substance use. 
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However, more research is needed to explore how mindfulness interventions exert their 




Drug use encompasses an increasingly broad range of substances (European 
Monitoring Centre for Drugs and Drug Addiction, 2018). There has been a 20-year 
downward trend in the consumption of legal drugs such as alcohol and tobacco, but a 
growing proportion of people consume illicit drugs (Seitz et al., 2019). Whilst the legal status 
of a drug does not necessarily directly correspond to the potential harms of the drug (Nutt 
et al., 2010), it can impact the societal and political responses to illicit drug use. There is a 
complex interplay between stigma, discrimination, criminalisation and healthcare provision 
(Global Commission on Drug Policy, 2017), with negative social and political representations 
of illicit drug users directly influencing clinical care (Schlag, 2020). Research indicates that 
users of illegal drugs have fewer harm reduction and intervention opportunities made 
available to them (Schlag, 2020). 
Patterns of substance use exist on a continuum from non-problematic to 
problematic (Global Commission on Drug Policy, 2017). Non-problematic substance use is 
defined as taking a substance for its intended purpose, including legal or illegal substances. 
This use could be under medical direction or taken recreationally to get high, with limited 
adverse consequences. Of those who consume illicit drugs, only a minority of people misuse 
them or use them in a problematic manner (Schlag, 2020). If a substance is used 
problematically, there is an increased risk that it may cause long-term physical and mental 
health difficulties for the user (Global Commission on Drug Policy, 2017). 
Substance misuse is costly not only to the individual and their families but also to 
society and is associated with significant levels of morbidity and mortality (Li et al., 2017). An  
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estimated 585,000 people globally died due to drug use in 2017 (United Nations Office on 
Drugs and Crime [UNODC], 2019). Substance misuse is also associated with high levels of 
mental health problems and increased social adversity, which causes a significant economic 
burden to society as a whole (Mirza et al., 2020). However, most substance users who want 
support are unable to access treatment, with only an estimated one in seven people 
diagnosed with a substance misuse disorder receiving treatment each year (United Nations 
Office on Drugs and Crime [UNODC], 2019).  
Part of the problem facing substance use services is that drug use is a complex and 
often relapsing, chronic condition (West & Brown, 2013). It requires a multi-faceted and 
coordinated care and intervention approach, needing co-operation between the criminal 
justice, social care, physical and mental health services. However, providing targeted and 
relevant services is challenging as the landscape of substance use is continuously changing. 
There are also many barriers to individuals accessing services, including the de-prioritisation 
of their own medical care, preferring to ignore the problem and perceived judgment from 
clinicians (Miller-Lloyd et al., 2020).  
Researchers investigating the development of harm reduction interventions for 
individuals with substance misuse difficulties are also met with barriers. Substance users, 
problematic or otherwise, are generally under-represented in surveys, especially those with 
intensive use patterns (Seitz et al., 2019). Researchers must also navigate the complex and 
changing political and social context in which their work is conducted (United Nations Office 
on Drugs and Crime [UNODC], 2019). Also, recent research suggests that the type of 
substance being used is an important factor to consider in providing interventions. For 
example, predictors of craving have been shown to vary significantly between alcohol, 
tobacco and illicit drugs (Enkema et al., 2020), potentially impacting relapse prevention 
support. With the broadening landscape of substances being used, research needs to keep 
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pace with the proliferation of novel drugs or new polysubstance use combinations. The 
barriers to research often prevent access to a sufficiently broad cross-section of the 
participant population to maximise generalisability. These include ethical considerations 
(e.g., capacity to consent) while ensuring confidentiality and protection from legal 
structures. 
Due to the relatively high levels of harm to the individual and impact on society, 
there is an ongoing need to evaluate cost-effective interventions that target substance 
cravings and prevent relapse. Despite the variety of evidence-based treatments available, 
long-term outcomes remain relatively poor, with relapse rates up to 60% in the 12 months 
posttreatment (Witkiewitz & Masyn, 2008). However, research into mindfulness-based 
interventions (MBIs) has yielded promising results for substance misuse treatment (Chiesa & 
Serretti, 2014; Li et al., 2017).  
 
Mindfulness-based treatment for substance misuse 
Mindfulness is defined as the individual's ability to purposefully bring attention and 
awareness to the present moment's experiences and relate to them in a non-judgmental 
way (Chiesa, 2017). Research suggests that people taught mindfulness learn to recognise 
internal experiences as temporary and subjective rather than permanent and accurate 
representations of reality (Katz & Toner, 2013). It is theorised that regular (e.g., daily) 
mindfulness practice translates into enduring changes in an individual's dispositional 
mindfulness in everyday life (Garland & Howard, 2018). Mindfulness training can help 
individuals increase insight into their own habitual cognitive and behavioural patterns and 
begin to respond consciously and deliberately (i.e., mindfully) rather than automatically (i.e., 
mindlessly) reacting to internal or external triggers (Katz & Toner, 2013). 
There is a growing evidence base that operationalising mindfulness into targeted 
interventions can be applied across various psychological disorders, including problematic 
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substance use. Examples include Mindfulness-Based Relapse Prevention (MBRP), which 
integrates mindfulness practice, and relapse prevention cognitive therapy and motivational 
interviewing (Bowen et al., 2011). An alternative is Mindfulness-Orientated Recovery 
Enhancement (MORE) which combines mindfulness training with positive psychology 
principles and cognitive behaviour therapy (CBT) (Garland et al., 2019). Operationalised and 
manualised mindfulness interventions are positively regarded by clinicians (Forbat et al., 
2015). Manualised interventions can also be deployed with higher levels of treatment 
fidelity, allowing their effectiveness to be evaluated within randomised control trials (RCTs). 
Manualised mindfulness-based interventions (MBIs) have been used to address a 
range of substance use difficulties associated with alcohol, tobacco and illicit drugs (Priddy 
et al., 2018). The most common MBIs relating to substance use difficulties (i.e., MBRP and 
MORE) are multi-week interventions, usually delivered in a group format, facilitated by a 
trained clinician (Katz & Toner, 2013). Sessions comprise psychoeducation and various 
experiential mindfulness practices such as body scan meditations and breathing exercises. 
Psychoeducation is usually delivered to address specific substance use experiences such as 
triggers, craving and affect regulation. Homework assignments often include self-monitoring 
of symptoms such as craving and mood fluctuations.  
Dispositional mindfulness, also known as trait mindfulness,  is a theoretically 
inherent human characteristic (Tomlinson et al., 2018).  It is theorised that interventions 
developing state mindfulness can increase trait mindfulness over time, and raise an 
individual's awareness of the automatic processes associated with attention to substance-
related cues and the presence of cravings (Katz & Toner, 2013). Extensive research has 
sought to identify the hypothetical mechanisms by which mindfulness is thought to modify 
the main features of substance use such as triggers, craving and relapse. It is thought that 
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increased awareness may disrupt the cycle of affect, cognitive and physiological mechanisms 
that maintain substance use (Katz & Toner, 2013).   
Mindfulness practice often involves focusing attention. A variety of practices include 
focusing on the sensation of breathing, a full-body scan or on specific parts of the body, or 
visual stimuli, such as a flame or mandala. The practice involves acknowledging but letting 
go of distractions without judgment. Increasing dispositional mindfulness in this way is 
positively associated with heightened executive control functioning (Garland, 2011).  
Research also suggests small but statistically significant negative correlations 
between trait mindfulness and craving (Garland, Roberts-Lewis, et al., 2014) and substance 
use (Karyadi et al., 2014a). As individuals with substance use disorders (SUDs) engage in 
mindfulness practices, they may learn to develop increased trait mindfulness, which has 
been theorised to protect against substance use and relapse (Li et al., 2017). Meta-analytic 
summaries of the effectiveness of MBIs with substance use difficulties reveal effect sizes 
from small to large on positive outcomes in cravings, affect and substance use (Priddy et al., 
2018) 
The relationship between stress and substance use is well-established, whereby 
increased levels of anxiety and depression are associated with an increased risk of substance 
misuse (Bowen et al., 2014). Different hypotheses have proposed various underlying 
mechanisms for this relationship. A systematic review suggested that negative emotional 
states are predictive of levels of substance craving and that developing a tolerance to 
heightened distress ameliorated this effect (Olsson et al., 2016). MBIs may reduce addiction 
behaviours through developing alternate stress management strategies, reducing the 
reliance on substances for relief from distress symptomology. 
Finally, it is thought that MBIs may attenuate addictive behaviours by providing an 
alternative to thought suppression. Conscious suppression of the urges associated with 
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substance use eventually exhausts the limited resources related to self-control (Stewart, 
2008). Ultimately this increases the intensity of cravings (Chiesa & Serretti, 2014). It has 
been demonstrated that mindfulness does not alter the frequency of these intrusive 
thoughts. However, after mindfulness training, individuals spend less time avoiding 
substance-related thoughts and urges, which has resulted in improvements in self-control 
and relapse rates (Bowen et al., 2007). 
 
Men and mindfulness interventions for problematic illicit substance use 
This review's narrower focus is specifically on the experiences of men who engage in 
problematic illicit substance use for several reasons. Historically men are much more likely 
than women to use illegal drugs recreationally (Becker et al., 2017). There are likely to be 
many reasons for this; one of the possible reasons may be related to social roles, with more 
stigma is attached to substance use and traditional women's roles (i.e., mother and 
caregiver; Kandall, 1999). Research suggests that whilst men are more likely to use illicit 
drugs, women are more likely to abuse prescribed drugs (McCellan, 2017).  
The overall rate of illicit substance use is higher in men, and the length of time 
between first substance use and seeking treatment often has a longer trajectory than 
women. That is, men are more reluctant to seek support (Elmquist et al., 2017). Being male 
is a significant but negative predictor of help-seeking behaviours (Gonzalez et al., 2011), with 
men being shown to be negatively associated with a willingness to actively seek substance 
use support (Sagar-Ouriaghli et al., 2019). As such, low mental health service use by males is 
observed across Western countries, where women are 1.6 times more likely to seek mental 
health treatment than men (Wang et al., 2005). 
Men are an understudied but important group to research (Elmquist et al., 2017). 
Not only because of their differential rates of illicit substance misuse and support-seeking 
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compared to women. Men are three times as likely to die from suicide than women (Key 
Data, 2014) and report overall lower life satisfaction (Personal Well-Being in the UK - Office 
for National Statistics, 2018). Men also make up a disproportionate number of the homeless 
and prison population (Key Data, 2014). In addition, it should also be noted that being a 
substance misusing man is also strongly associated with conviction and incarceration into 
prison, and reconviction (Light et al., 2013), homelessness and suicide (Lee et al., 2017). 
Research focussing on a male population would help better understand why some men 
exhibit such vulnerabilities, and the impact this may have on support provision. 
 
Current Systematic Review and Meta-Analysis 
Numerous systematic reviews and meta-analyses have been published that support 
the positive effects of mindfulness treatment on substance misuse problems (Katz & Toner, 
2013; Li et al., 2017; Priddy et al., 2018). However, no meta-analyses were found to have 
been published that examined the efficacy of mindfulness treatment in reducing substance 
misuse with a specific focus on men and illicit drugs. The focus on illegal drugs is not driven 
by their legal status, as the legal status does not necessarily directly correspond to the 
potential harms of the drug (Nutt et al., 2010). However, a distinction was made against 
legal drugs (e.g., alcohol and tobacco) as the prevalence of illegal substance users is 
increasing, and the users are under-represented in research (Seitz et al., 2019). 
Thus, a systematic review and meta-analysis were conducted that included 
published, English-language RCTs of MBIs for treating illegal substance misuse difficulties 
published by January 2021. This systematic review evaluated the methodological 
characteristics and substantive findings of studies to assess the effects of mindfulness 
interventions for men with illicit substance misuse. As substance cravings are a significant 
predictor of substance use and relapse (Witkiewitz et al., 2013), a meta-analysis was 
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conducted to estimate the treatment effect sizes of mindfulness interventions on substance 
cravings. It is hoped that this study's findings will increase understanding of the efficacy and 




This review only includes published journal articles describing randomised control 
trials (RCTs) of mindfulness for men treated for a substance use disorder, specifically illegal 
drugs. The following inclusion criteria were applied: (1) Published RCTs; (2) participants were 
aged 18 or over; (3) participants diagnosed with a substance use disorder; (4) studies with 
male-only participants; and (5) utilised a mindfulness-based intervention. Exclusion criteria 
were as follows: (1) involved non-randomised trials; (2) the primary focus was the treatment 
of alcohol and tobacco-related addiction; (3) mixed-gendered or female-only participants; 
and (4) not published in the English language. No restrictions were set on the type of control 
group used, the method of delivery of the mindfulness intervention, nor the outcomes 
assessed, as all outcomes were of interest. 
 
Search Strategy 
A systematic search was performed in three online databases (i.e., PsycINFO, 
PubMed and Web of Science) for articles up to 26th January 2021. The search strings used 
were "mindfulness" OR "mindfulness intervention" OR "mindfulness meditation" OR 
"mindfulness treatment" OR "mindfulness-based relapse prevention" OR "MBRP" AND 
"substance misuse" OR "substance use" OR "drug abuse" OR "*use disorder". Free-text 
searches of the databases were conducted using Boolean operators and truncations. In 
addition, the reference lists of selected eligible articles were searched to identify any 




The original search returned a total of 869 articles. After de-duplication, 589 articles 
remained to be screened by title and abstract. The researcher initially screened all the 
identified abstracts, and a second reviewer assessed a random sample of 70 of the abstracts 
(12%). There was a very high level of agreement between the raters, Cohen's kappa = 0.84 
(McHugh, 2012), and the few disagreements were resolved by discussion. 571 articles were 
deemed irrelevant to the review because: (1) they did not include mindfulness treatment; 
(2) did not use a randomised controlled trial design; (3) included female participants; (4) 
participants were children/adolescents; or (5) the participants were primarily being treated 
for alcohol or tobacco use.  
18 articles were identified as being potentially eligible for inclusion. The full-text 
versions of the 18 selected articles were retrieved, and the exclusion/inclusion criteria were 
used to assess whether each study was eligible for inclusion in the review. The eligible 
studies' reference lists were searched for any other potentially relevant articles. One 
additional trial was identified for inclusion when reviewing the eligible studies' reference 
lists (Yaghubi & Zargar, 2018). Full texts from the eligibility screen (19 studies) were 
reviewed and evaluated for eligibility by the researcher and a second reviewer. A consensus 
was reached to include a total of seven studies in the analysis. Figure 1. shows a flow 















A data form was developed to extract data from the final seven selected studies. 
The data extraction protocol was piloted with two randomly chosen studies and refined 
accordingly. Extraction of the following data was conducted: (1) participant’s demographic 
characteristics; (2) intervention, including format and duration; (3) control group details; (4) 
treatment adherence; (5) outcomes of interest; and (6) limitations. A reviewer read all the 
studies independently to ensure the accuracy of the extracted data. Disagreements 
regarding extracted data were few and resolved via discussion. The author and reviewer 














Articles derived from: 




Articles screened by title 
and abstract 
n = 589 
Articles selected for full text 
screening: 
n = 18 
Included articles: 
n = 7 
Duplicate articles removed 
n = 280 
Articles excluded that did not fit with 
the inclusion criteria: 
Gender: n = 150 
Study Design: n = 14 
Age: n = 17 
Alcohol/tobacco studies: n = 262  
Mindfulness: n = 128 
Total: n = 571  
Full articles excluded: 
Intervention: n = 2 
Study design: n = 10 
Total: n = 12 
Additional record identified:  
n = 1 
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Quality Assessment 
Each study's methodological quality was rated using the Methodological Quality 
Rating Scale (MQRS; Miller et al., (1995)). The MQRS has been widely used in systematic 
reviews and meta-analyses examining substance misuse treatments (e.g., Apodaca & Miller, 
2003; Vaughn & Howard, 2004; Li et al., 2017). This scale assesses 13 dimensions of 
methodological attributes.  Table 1 shows the 13 dimensions and summary results for the 
final seven studies.  
 
Table 1 
Methodological Quality Rating Scale (MQRS; Miller et al., 1995) 
Methodological 
Attributes Scores assessed % (N) 
A. Study Design  
 
1 = Single Group pretest postest 
2 = Quasi-experimental (nonequivalent control) 




B. Replicability  0 = Procedures contain insufficient detail 
1 = Procedures contain sufficient detail 
28.6% (2) 
71.4% (5) 
C. Baseline  0 = No baseline scores, characteristics or measures reported 
1 = Baseline scores, characteristics, or measures reported 
0% (0) 
100% (7) 
D. Quality Control  0 = No standardization specified 
1 = Intervention standardization by manual, specific training etc. 
14.3% (1) 
85.7% (6) 
E. Follow-up length  0 = Less than 6 months 
1 = 6 to 11 months 




F. Dosage  
 
0 = No discussion of dosage or % of treatment received 
1 = Dosage, %treatment enumerated and accounted for 
71.4% (5) 
28.6% (2) 
G. Collaterals  
 
0 = No collateral verification 





0 = No objective verification 
1 = Verification of records (paper records, blood, materials) 
57.1% (4) 
42.9% (3) 
I. Dropouts / attrition
  
0 = Dropouts neither discussed nor accounted for 
1 = Dropouts enumerated and discussed 
42.9% (3) 
57.1% (4) 
J. Statistical Power  0 = Inadequate power due to sample size / dropouts 
1 = Adequate power with adequate sample size 
57.1% (4) 
42.9% (3) 
K. Independent  0 = Follow-up nonblind, unspecified 
1 = Follow-up of interventions treatment blind 
0% (0) 
100% (7) 
L. Analyses  0 = No statistical analyses or clearly inappropriate analyses 
1 = Appropriate statistical analyses (group differences) 
0% (0) 
100% (7) 
M. Multisite  
 
0 = Single site or comparison of differing intervention 





Total scores range from 0 (lowest quality) to 16 (highest quality). Each study was 
assessed and scored independently by two raters using the MQRS. An inter-rater reliability 
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analysis using Cohen's kappa was performed to determine consistency between the two 
raters. Cohen's kappa was calculated for each study, and the agreements ranged from 0.72 
(substantial) to 1.00 (perfect) (McHugh, 2012). This indicates a high level of agreement 
across all the studies. The individual Cohen's kappa scores for the studies are in Appendix B. 
Any discrepancies of rating were discussed, and a consensus was agreed upon between the 
two raters. A summary of the final MQRS ratings for each study is found in Appendix C. 
 
Statistical Analysis 
A meta-analysis was performed to estimate the effect size of MBIs on levels of 
substance cravings at posttreatment compared to control conditions. Substance craving is 
an important predictor of substance use and may deter individuals from stopping (Sayette, 
2016). It was also the only measure to be consistently used in all the studies identified 
during the systematic review process. Studies were also assessed to ensure that datasets 
were independent of each other and was not shared between them (i.e., they were not part 
of a joint clinical trial).   
The outcome measures used to quantify levels of craving at posttreatment varied 
between the studies. The standardised measures, and the studies that employed them are; 
Heroin Craving Questionnaire (Abed & Shahidi, 2019; Foroushani, 2019), Stimulant Use and 
Craving (Carrico et al., 2019); Drugs Avoidance Self-Efficacy Scale (Lee et al., 2011); Craving 
Beliefs Questionnaire (Yaghubi & Zargar, 2018); Penn Alcohol/Drug Craving Scale (Lyons et 
al., 2019) and the Obsessive-Compulsive Drug Use Scale – Craving (Chen et al., 2019). These 
standardised measures were all continuous variables. The meta-analysis was performed by 
computing standardised mean differences in posttreatment values of outcome variables 
between the mindfulness and control conditions. 
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Hedge's g and associated 95% confidence intervals (CIs) were computed for each 
study as appropriate and pooled. Hedge's g was selected as it has better small sample 
properties and more suitable when the sample sizes between studies are different (Lac, 
2014). The meta-analysis was conducted using The Cochrane Collaboration's Review 
Manager v5.4 program (Review Manager; RevMan, 2020). The meta-analytic model utilised 
a random-effects methodology due to the known variation in the study's settings, 
participant populations and treatment modalities. The random-effects model assumes a 
more significant underlying heterogeneity between the sample estimates and produces a 
wider confidence interval for the combined overall effect (Mosteller & Colditz, 1996). The 
random-effects model also incorporates between-study variation into the study weights and 
estimated effect size (Harris et al., 2008).  
The magnitude of Hedge's g was interpreted using Cohen's description of 0.20 as 
small, 0.50 as medium, and 0.80 as large (Cohen, 1988). Heterogeneity of effect sizes was 
assessed using Cochran's Q statistic (χ2) to investigate whether there was a significant 
variation of effect sizes between studies. The I2 index was used to measure the magnitude of 
heterogeneity. I2 measures the degree to which variability of effect sizes between studies is 
due to heterogeneity rather than chance and is reported as a percentage. The magnitude of 
heterogeneity ranges from 0% (i.e., homogeneity), 25% equates to small levels of 








Characteristics of the selected studies 
 
A total of seven studies were included in this systematic review, examining the 
effects of mindfulness interventions on men with illicit drug use problems. A detailed 
summary of the study characteristics can be found in Table 2. 
All the studies employed randomised controlled trial (RCT) designs and were 
published between 2011 and 2019. Five of the studies (71.4%) did not disclose the  dates 
over which they were conducted (Abed & Shahidi, 2019; Chen et al., 2019; Foroushani, 2019; 
Lee et al., 2016; Lyons et al., 2019); the other two took place between 2013 and 2017 
(Carrico et al., 2019; Yaghubi & Zargar, 2018). The studies were conducted in various 
countries; three (42.9%) in Iran (Abed & Shahidi, 2019; Foroushani, 2019; Yaghubi & Zargar, 
2018), two (28.6%) in the United States (Carrico et al., 2019; Lyons et al., 2019) and one 
(14.3%) in Taiwan (Lee et al., 2016) and China (Chen et al., 2019). The source of sponsorship 
was disclosed in only two (28.6%) of the studies. These were the National Institute on Drug 
Abuse, US (Carrico et al., 2019) and the National Natural Science Foundation of China (Chen 
et al., 2019). 
Most of the studies (71.4%) recruited from community drug treatment centres 
(Abed & Shahidi, 2019; Carrico et al., 2019; Foroushani, 2019; Lee et al., 2016; Yaghubi & 
Zargar, 2018), one (14.3%) from a compulsory drug rehabilitation centre (Chen et al., 2019), 
and one (14.3%) from a court-ordered drug treatment program in a prison (Lyons et al., 
2019). Most of the studies (57.1%) evaluated populations being treated for opioid addiction 
(Abed & Shahidi, 2019; Chen et al., 2019; Foroushani, 2019; Yaghubi & Zargar, 2018), 14.3% 
methamphetamine addiction (Carrico et al., 2019), with 28.6% treating an undisclosed illicit 
drug addiction (Lee et al., 2016; Lyons et al., 2019) .
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Table 2 
Characteristics of Included Studies (n=7) 
Study Data collection 
time points 
Treatment condition Control 
Condition 































tests - the first, second 
and third month 
following the MBRP 
intervention. 
Decreases in three out of the 
five subscales of HCQ. Urine 
drug tests indicated fewer 
lapses in the experimental 
group. 
 
Small sample size, low power. 
Limited information on the 
recruitment process of participants. 
No description of the control 





6 Months,  






















aged between 24 
and 59 (M=432.2). 
HIV Positive, 
methamphetamin
e users. Ethnicity: 
Black / African 
American - 16% 
White - 43% 
Hispanic - 29% 
Other - 12% 
HIV viral load / CD$ T-
cell count - Baseline, 6 
Months, 12 Months, 
15 Months. 
Differential Emotions 
Scale (DES) and 
Stimulant Use and 
Craving - Baseline, 
Session 1, 2 and 3. 3 
months, 6 Months, 12 
Months, 15 Months. 
Significantly lower HIV viral 
load at six, twelve and 
fifteen months compared to 
the control condition. 
Significant increases in 
positive affect and decreases 
in the frequency of stimulant 
use at six and twelve 
months. 
Small sample size and low 
generalisability.  
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Chen et al., 
2019 
The participants 
were followed up 
at 1, 3, 6, 






Energy (MSDE). 24 
daily sessions, 6 
days a week (1.5 - 
6hrs) 
Treatment as 







aged between 20 
and 50. 
 
Abstinence Rates - 
participants were 
followed up at 1, 3, 6, 
12, 24, and 36 
month(s) after their 
discharge. 
Contemplation Ladder 
(CL) - Readiness to 
change, Obsessive 
Compulsive Drug Use 
Scale (OCDUS) - 
Craving, Beck 
Depression Inventory 
Significant increase in 
Contemplation Ladder score 
and reduction on the 
OCDUS, BDI, and Aggression 
Questionnaire. The 
intervention group reported 
significantly higher 
abstinence rates and 
retention rates at follow-up. 
Small sample size. Attrition rates 
were high. Lack of motivation to 
change may be related in part to 
the low retention rates. Abstinence 
of the participants was self-
reported, which may raise a 
concern about the reliability and 
validity of the abstinence rates. 
12 
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Study Data collection 
time points 
Treatment condition Control 
Condition 
Sample Outcome measures Results Limitations MQRS 
score 
(BDI) - Depression and 
the Aggression 
Questionnaire (AQ) – 
Aggression - 
participants were 
followed up at 1, 3, 6, 
12, 24, and 36 











(MBRP). Period of 

















- Pre- and 
posttreatment, three 
months follow-up. 
Urine tests - The first, 
second and third 
month following the 
intervention. 
Three out of the five 
subscales of HCQ were 
significantly influenced by 
MBRP, while this prevention 
programme significantly 
influenced all the 
mindfulness questionnaire's 
five facets. Urine tests 
revealed a lower 
lapse/relapse percentage in 
the experimental groups. 
 
Study dates are unknown; neither 
are the inclusion or exclusion 
criteria disclosed. No description of 
the control group. Unknown 
sponsorship. 
9 










Usual (TAU).  
No specifics 
were given. 
24 male inmates, 








Efficacy Scale (DASE), 
Beck Depression 
Inventory-II (BDI-II) - 
Intervention Group 
completed the BDI 
weekly. Both groups 
completed all other 




differences were found on 
positive outcome 
expectancies or self-efficacy. 
BDI-II scores among MBRP 
participants showed a 
downward trend over time. 
A group x time effect 
emerged for negative 
outcome expectancies, with 
significant differences 
between groups at post-
course assessment.  
Small sample size, low power. 
Unknown method of recruitment. 
No description of the control group 
No longer-term follow-up 
assessment 
7 










189 male inmates, 




The psychosocial measures 
of anxiety, drug craving, and 
PTSD at baseline measures 
Participants were not able to be 
followed in the community to 
assess substance use after release 
9 
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Study Data collection 
time points 
Treatment condition Control 
Condition 
Sample Outcome measures Results Limitations MQRS 
score 
week program, 75 









American - 58.9% 









Scale, PTSD Symptom 
Checklist - Baseline, 
Follow-up 
were significantly positively 
correlated with one another 
and negatively correlated 
with mindfulness, as 
measured by the FFMQ and 
FMI. PTSD and craving scores 
declined while mindfulness 
scores on the Freiburg scale, 
though not the FFMQ, 
increased.  
 
There were no significant 
differences in other 
psychological outcomes. 
 
from jail. The follow-up rate of 69% 
was low, primarily because 
participants were released or 
transferred. As both the treatment 
and comparison interventions took 
place in a therapeutic jail 
community, the authors cannot 
distinguish the effects of MBRP 
from the beneficial effects of other 










(MBRP). 8 weekly 














aged between 20 
and 50. 
Quality of Life (QOL), 
Craving Beliefs 
Questionnaire (CBQ) - 
Pre- and 
posttreatment, two-
month follow-up.  
The results of repeated-
measures ANOVA showed no 
significant difference 
between intervention and 
control groups in the pre-
test. Still, MBRP in the 
intervention group 
significantly increased the 
scores of QOL and decreased 
the scores of craving 
significantly. 
Limitations of this study include 
research sample limitation to men 
and short duration of follow-up. To 
raise the generalisability and 
reliability, further studies with 




Sample sizes ranged from 24 to 189, with most studies (57.1%) reporting adequate 
power with a sufficient sample size (Carrico et al., 2019; Chen et al., 2019; Lyons et al., 2019; 
Yaghubi & Zargar, 2018). 
The studies evaluated different types of mindfulness intervention, including  
Mindfulness-based relapse prevention (MBRP; Abed & Shahidi, 2019; Foroushani, 2019; Lee 
et al., 2016; Lyons et al., 2019; Yaghubi & Zargar, 2018) and Affect Regulation Treatment to 
Enhance Methamphetamine Intervention Success (ARTEMIS; Carrico et al., 2019). One study 
included mindfulness training as an adjunct to Eye Movement Desensitisation and 
Reprocessing (EMDR) in a treatment known as Motivation-Skill-Desensitisation-Mental 
Energy (MSDE; Chen et al., 2019). 
As the studies used different adaptations of mindfulness-based interventions, the 
intervention's length varied between the studies. Two studies had intervention lengths of 
four to six weeks (Chen et al., 2019; Lyons et al., 2019), three studies had eight-week 
interventions (Abed & Shahidi, 2019; Foroushani, 2019; Yaghubi & Zargar, 2018), with two 
studies having intervention durations of ten to thirteen weeks (Carrico et al., 2019; Lee et 
al., 2016). Therefore, it is important to consider when comparing studies that the time 
between the pre-and posttreatment measures varies depending on the study design. 
Appendix C presents the seven studies' characteristics and major findings and their 
methodological attributes as reviewed using the Methodological Quality Rating Scales 
(MQRS). Each study was evaluated by two raters with high levels of agreement. The average 
measure Intraclass Correlation Coefficient (ICC) was .99 with a 95% confidence interval from 
.96 to .99 (F(12)=88.34, p<.001). The MQRS scores across the seven studies ranged between 
seven (Lee et al., 2016; Yaghubi & Zargar, 2018) and thirteen (Carrico et al., 2019). The mean 
score was 9.60 (SD=2.30). Overall, the methodological qualities of the studies ranged from 
medium to high.  
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All studies reported the extent to which randomisation successfully managed group 
baseline characteristics. When randomisation was not completely successful, the studies 
disclosed the analytical strategies used to control baseline group differences between 
participants in the intervention and control conditions (e.g., ANCOVA). 
Six out of seven studies (85.7%) reported baseline sample characteristics and 
outcome measures. All studies were evaluated using appropriate statistical analyses that 
compared differences in outcomes between the intervention and control groups. The 
majority of studies provided details of the procedures in sufficient detail to allow for 
replication (85.7%), employed intervention standardisation of the manual and procedures 
(71.4%), and enumerated the study attrition rates (85.7%). However, only a minority of 
studies accounted for treatment dosage (i.e., the proportion of the total number of sessions 
participants attended; 42.9%), and only 42.9% employed an objective verification of 
outcome variables (e.g., urine tests). None of the studies used collateral interviews to 
validate participants' self-reports. Additionally, only a minority of studies followed up 
participants after six months (42.8%), and only one study conducted follow up by 
independent interviewers who were blind to group assignment (14.2%).  
 
Effects of mindfulness treatment on substance misuse 
Five RCTs compared mindfulness interventions to treatment as usual (TAU) conditions 
(Abed & Shahidi, 2019; Chen et al., 2019; Foroushani, 2019; Lee et al., 2016; Yaghubi & Zargar, 
2018), with two RCTs comparing the intervention against a neutral attention control group 
(Carrico et al., 2019; Lyons et al., 2019). The majority of the studies found that mindfulness 
interventions were associated with favourable substance misuse treatment outcomes at 
posttreatment and follow-up compared to control conditions, except for one study (Lee et al., 
2016). Specifically, mindfulness interventions were superior to control conditions, such as  
 31 
treatment as usual or neutral attention control groups, to reduce the level of craving for 
substance use (Abed & Shahidi, 2019; Carrico et al., 2019; Chen et al., 2019; Foroushani, 2019; 
Lyons et al., 2019; Yaghubi & Zargar, 2018) and increased abstinence rates (Abed & Shahidi, 
2019; Carrico et al., 2019; Chen et al., 2019; Foroushani, 2019). Mindfulness intervention was 
demonstrated to be more effective in reducing craving, substance use, and increasing 
abstinence than TAU alone (Abed & Shahidi, 2019; Carrico et al., 2019; Chen et al., 2019; 
Foroushani, 2019). Additionally, five RCTs demonstrated that mindfulness intervention was 
more effective in increasing abstinence rates at posttreatment and follow-up, compared to 
the control support group (Abed & Shahidi, 2019; Carrico et al., 2019; Chen et al., 2019; 
Foroushani, 2019; Yaghubi & Zargar, 2018).  
Contrary to the positive findings described above, Lee et al. (2016) did not observe 
significant differences between the MBRP intervention and TAU control condition in 
increasing drug avoidance at posttreatment. However, this study may have been limited due 
to significant differences in drug use between the experimental and control conditions at 
baseline. The study's low statistical power may further reduce the quality of this study due 
to the small sample size (N = 24). 
 
Effect sizes of mindfulness treatment posttreatment outcomes 
All seven studies provided sample sizes for the intervention and comparison 
conditions. They also provided sufficient information to calculate the effect size, including 
means and standard deviations for levels of substance cravings posttreatment. Using the 
Cochrane Collaboration's Review Manager software (Review Manager; RevMan, 2020), a 
meta-analysis was conducted for the seven RCTs comparing the effects of mindfulness 
intervention to control conditions on posttreatment values of substance craving. Table 3 
shows the effect sizes and associated 95% CIs of mindfulness treatments of substance 
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Summary Data and Effect Sizes of Mindfulness Interventions on Substance Craving at 
Posttreatment Relative to a Control Condition  
Study Intervention Control Group     
 n Mean SD n Mean SD Weight Hedge's g 95% CI 
Abed & Shahidi, 2019 24 18.93 1.75 29 31.66 3.12 12.65% 4.84 3.82 6.00 
Carrico et al., 2019 55 1.79 1.36 55 2.56 1.69 15.64% 0.50 0.12 0.88 
Chen et al., 2019 46 30.74 11.83 43 39.58 7.84 15.47% 0.87 0.44 1.31 
Foroushani, 2019 12 16.23 1.78 15 32.26 3.71 11.39% 4.04 2.80 5.54 
Lee et al., 2011 10 40.40 1.26 12 41.36 3.29 13.91% 0.36 -0.49 1.24 
Lyons et al., 2019 54 8.00 3.20 71 8.90 4.20 15.70% 0.24 -0.12 0.59 
Yaghubi & Zargar, 2018 35 67.46 11.14 33 82.63 18.57 15.25% 0.99 0.49 1.51 
           
Total 236   258   100.00% 1.53 0.68 2.37 
           
Heterogeneity: Tau2= 1.13, Chi2 = 99.84, df = 6 (p<.0001), I2 = 94% 
 
The seven studies' sample sizes varied from 24 to 189 (M=87.3, SD=52.9), and the 
number of participants completing posttreatment assessments ranged from 24 to 126 
(M=70.1, SD=32.0). The synthesised effect size for the seven studies was calculated (Hedge’s 
g = 1.53, 95% CI 0.68 to 2.37). The meta-analysis' results showed very high heterogeneity 
across the studies in the meta-analyses of craving (I2 = 0.94). A Forest plot was also 
generated to display the effect sizes for each of the studies (Figure 2). 
 
Figure 2 
Forest Plot Displaying Random-Effects Meta-Analysis for the Effect of a Mindfulness 
Intervention on Substance Craving at Posttreatment Relative to a Control Condition 
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Total
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The presence of publication bias was evaluated by analysing funnel plot asymmetry 
(Figure 3) and using Egger's test (Egger et al., 1997) and Begg and Mazumdar's test (Begg & 
Mazumdar, 1994). Both Egger's regression (p = 0.023) and Begg and Mazumdar's test 
(p=0.024) suggest the presence of publication bias of funnel plots for craving. The outer 
dashed lines indicate the triangular region within which 95% of studies are expected to lie in 
the absence of both biases and heterogeneity.  
 
Figure 3 
Funnel Plot to Evaluate Publication Bias among Studies Included in the Meta-Analysis for the 
Effect of a Mindfulness Intervention on Craving.  
 
 
The funnel plot of substance craving showed some asymmetry, suggesting that 
studies with small sample sizes showing the nonsignificant effect of mindfulness treatment 
were missing from the meta-analyses. The asymmetry of the funnel plot may also be 
attributable to the large between-study heterogeneity. 
With the potential exclusion of studies with nonsignificant findings, synthesised 
effect sizes of mindfulness treatment on cravings may be overestimated. The trim and fill 





















& Tweedie, 2000) was considered. However, this was not used due to the potential bias 
introduced by the heterogeneity found between the studies, high levels of heterogeneity 
having been found to affect the validity of this method (Peters et al., 2007). 
Overall, the results from the funnel plots, Egger's and Begg and Mazumdar's tests, 
suggested that the meta-analyses’ results were likely to be affected by publication bias. 
However, the funnel plots need to be interpreted cautiously due to the small number of 




This systematic review and meta-analysis evaluated seven randomised control trials 
(RCTs), published between December 2011 and November 2019. The therapeutic benefits of 
mindfulness-based interventions (MBIs) were examined in male populations of illicit 
substance users across various treatment settings. This review supports the promising 
effects of MBIs in treating men with substance use difficulties within community treatment 
programs and prison settings. Furthermore, the results of the meta-analyses revealed that 
individual studies demonstrated small-to-large effect sizes for the mindfulness interventions 
on reducing craving for substance use, compared with control conditions. 
In the systematic review, most studies reported that mindfulness-based 
interventions effectively reduced substance use and increased abstinence at posttreatment 
and follow-ups ranging from 1-month to 36-months posttreatment. The RCTs indicate that 
mindfulness-based interventions produced more positive outcomes when compared with 
treatment as usual (TAU) or neutral attention control groups. However, one study failed to 
find any statistically significant different results between intervention and control groups 
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posttreatment (Lee et al., 2016), although this could be partially explained by the study's 
significantly different baseline group measures.   
Where positive treatment outcomes were found, most of the gains were reported to 
be maintained in the longer term. However, overall, the results at follow-up were mixed. 
Some studies reported sustained positive outcomes after posttreatment (Abed & Shahidi, 
2019; Chen et al., 2019; Foroushani, 2019; Yaghubi & Zargar, 2018). However, other studies 
reported that the differences between the MBI and TAU groups were no longer statistically 
significant (Carrico et al., 2019) or were only reported on narratively (Foroushani, 2019). 
Two studies had not incorporated follow-ups into their study design (Lee et al., 2011; Lyons 
et al., 2019). The most extended follow-up period of the included studies was 36 months 
(Chen et al., 2019). This study suggests that the long-term effectiveness of MBIs on 
abstinence rates appears to diminish with time. However, with high participant attrition 
levels in this study, these results should be interpreted with caution and may be 
circumstantial to the characteristics of this study. Further research should explore to what 
extent continuous mindfulness practise is required to maintain the short-term increase in 
abstinence rates over time. 
In contrast to the others, one RCT in this review did not support an effect of 
mindfulness treatment in decreasing drug avoidance self-efficacy and frequency of drug use 
measures at posttreatment compared to a treatment as usual control group (Lee et al., 
2011). Although comparing posttreatment outcomes between the treatment and control 
groups elicits a positive effect, the differences became nonsignificant when controlling for 
the two groups' baseline characteristics. It should be noted that this study scored the lowest 
in the quality assessment using the MQRS. Methodological design characteristics that 
potentially affected this study's interpretability include the small sample size, leading to low 
statistical power to detect significant effects. In addition, the study did not have a 
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description of the control group conditions nor details of the randomisation process. 
Furthermore, the study's measures were locally translated and adapted by the author, and 
the psychometrics for the adapted scales were not reported in the article.  
The reviewed studies' retention rates were generally high, with several studies 
reporting that retention in the treatment groups was higher than the control groups (Chen 
et al., 2019; Yaghubi & Zargar, 2018).  As the treatment did not adversely impact retention 
rates for MBIs, this supports the premise that MBIs are suitable for treating people with 
substance use difficulties.  
The RCTs in this review provided detailed sufficient statistical information - means 
and standard deviations - on the outcome variable of interest (i.e., craving) measured at 
posttreatment. As such, it was possible to obtain accurate effect sizes of the interventions 
for a meta-analysis. Overall, the meta-analysis of the RCTs supported the positive findings 
from the systematic review.  
The meta-analysis indicated that mindfulness interventions could alter underlying 
risk mechanisms for cravings for substance use. These findings are potentially significant 
because craving and substance use as a coping response for distress are established as 
predictors of relapse (Hartz et al., 2001). Mindfulness treatments may reduce cravings by 
facilitating people's metacognitive awareness of their craving experience and the presence 
of urges (Elmquist et al., 2017). Increasing awareness of these triggers may enable people to 
disengage their attention from distressing experiences and substance-related urges that 
could trigger substance use and reorient their attention to health-promoting stimuli 
(Garland et al., 2014). Studies also suggest that mindfulness training could reduce craving 
through cultivating awareness and acceptance of, and nonreactivity to, craving without 
engaging in addictive responses (Enkema et al., 2020; Garland et al., 2014). Mindfulness is 
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also thought to be a metacognitive coping strategy by enhancing awareness of relapse risk 
triggers (Marlatt & Donovan, 2005). 
The overall strength of the relationship between MBIs and substance craving was 
quantified by synthesising the studies' empirical results through meta-analysis. However, 
due to the degree of heterogeneity between studies, these results should be interpreted 
cautiously. A random-effects model was employed in the meta-analysis, due to the known 
differences in treatment modality and participant populations, even though this results in a 
less accurate assessment of the impact of the intervention (Sedgwick, 2015). However, 
despite all the studies included within the meta-analysis measuring the same theoretical 
hypothesis that MBIs reduce cravings in men with substance use difficulties, synthesising the 
findings across studies was problematic due to the high degree of heterogeneity. Although 
the studies had the same outcome direction of mindfulness having a positive outcome effect 
on substance use craving, the meta-analysis' heterogeneity revealed effect sizes of different 
magnitudes. The effect sizes of the individual studies ranged from 0.24 to 4.84. However, 
from the forest plot (Figure 2) and the funnel plot (Figure 3), the effect sizes of two of the 
studies are potential outliers (Abed & Shahidi, 2019; Foroushani, 2019), having markedly 
different findings compared to the other five. The effect sizes for the two outlier studies 
were 4.84 and 4.04, compared with the range for the other five being 0.24 to 0.99. It is not 
uncommon for outliers to occur in meta-analyses and could be the results of chance alone 
(Viechtbauer & Cheung, 2010). However, as it is very difficult to distinguish between large 
sampling errors and actual erroneous data, some researchers recommend against examining 
the influence of outliers in meta-analyses (Hunter & Schmidt, 2004).  
This degree of variability in effect sizes was unexpected, and no theory-driven 
explanation was considered a priori and may reflect underlying study variations. For 
example, differences in the research setting (i.e., community treatment and prison settings), 
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demographics (i.e., ethnicity, primary language), or methodological alterations due to 
cultural or contextual differences (i.e., whether culturally sensitive adaptations were used) 
(Lac, 2014). A diagnostic quantitative, post-hoc subgroup analysis to examine study 
characteristics that could explain the heterogeneity was not conducted. Conducting multiple 
analyses without an a priori theoretical basis increases the risk of a Type I error (Higgins, 
2003). Type 1 errors are finding an apparent but false explanation for the heterogeneity by 
considering many different characteristics). However, future research may consider 
scrutinising the identified outliers in terms of their study design, as this may lead to new 
insights about characteristics that may act as potential moderators (Viechtbauer & Cheung, 
2010). For example, the studies with large effect sizes may indicate study parameters that 
produce these types of effects (Mosteller & Colditz, 1996).  
However, in the absence of a quantitative sub-group analysis, a post-hoc narrative 
explanation could be associated with both outlier studies having very small sample sizes and 
reported low statistical power. Other factors may have been introduced by the systematic 
review’s study criteria or comparing the different mindfulness-based interventions (e.g., 
MBRP, ARTEMIS and MSDE). Although, a recent meta-analysis of a range of mindfulness 
treatment for substance misuse found that virtually all treatments were associated with 
positive outcomes despite the methodological heterogeneity (Li et al., 2017).  
It is also important to note that the seven studies used different measures to assess 
substance craving, including the Heroin Craving Questionnaire – HCQ (n=2), Drugs Avoidance 
Self-Efficacy Scale – DASE (n=1), Stimulant Use and Craving (n =1), the Craving Beliefs 
Questionnaire – CBQ (n=1), the Obsessive-Compulsive Drug Use Scale - OCDUS – Craving 
(n=1), and the Penn Alcohol/Drug Craving Scale (n = 1). As these measures may demonstrate 
differential temporal sensitivities, this may introduce further bias into the analysis. 
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Another source of variance between the studies is the different types of illicit drugs 
being treated (e.g., opiates, methamphetamine etc.). Drug type has been hypothesised to be 
an important factor in differences in substance craving outcomes in intervention studies 
(Enkema et al., 2020). Research suggests that the associations between affect and cravings 
may differ according to substance type, with different mood states triggering cravings 
depending on the substance type (Serre, 2018). While this meta-analysis' findings are 
exploratory and data-driven, the high degree of heterogeneity means that the results should 
be interpreted with caution (Viechtbauer & Cheung, 2010). However, further investigation 
may reveal potentially interesting avenues for future research. 
In addition to measuring abstinence and substance cravings, most studies in this 
review examined changes in other psychological functions associated with substance misuse 
(Carrico et al., 2019; Chen et al., 2019; Foroushani, 2019; Lee et al., 2016; Lyons et al., 2019; 
Yaghubi & Zargar, 2018). Findings from these studies indicate that MBIs were associated 
with posttreatment increases in positive affect (Carrico et al., 2019; Chen et al., 2019; Lee et 
al., 2016), reductions in aggression (Chen et al., 2019), improvements in trait mindfulness 
(Lyons et al., 2019) and quality of life (Yaghubi & Zargar, 2018). These reports reinforce 
findings that MBIs can facilitate a range of positive health outcomes amongst substance 
users thought to be influential in cravings and relapse.  
The current review focused on sample populations of males with problematic illicit 
substance use, excluding any mixed gendered or female-focused research, and studies 
primarily focused on legal drug misuse, particularly alcohol and tobacco use. This study 
broadly supports a recent systematic review and meta-analysis that focused on a broader 
population of participants, including legal and illegal substance use (Li et al., 2017). The 
authors evaluated 42 mixed gendered, or female only, studies and evaluated treatments for 
mixed substance misuse presentations (i.e., alcohol, alcohol and illicit drugs or illicit drugs 
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only). This review also revealed small to large effects of MBIs, with an overall synthesised 
effect size of 0.62, reporting similar positive outcomes of mindfulness treatments at 
posttreatment relative to a comparison condition. A further systematic review evaluating 
gender differences in the effectiveness of MBIs for substance use disorders found that whilst 
MBIs show positive outcomes for substance use behaviours, it demonstrated mixed results 
for gender differences. It recommended further research, including gender as an 
independent variable (Katz & Toner, 2013). 
 
Strengths and Limitations 
The overall strength of the systematic review process was improved by having the 
study selection process assessed by two independent raters. The second rater evaluated 
12% of the abstracts and all the full papers. In doing so, the decision-making process was 
less susceptible to personal biases. Inter-rater reliability was high, and any disagreements 
were resolved between the raters through discussion. Similarly, the quality assessment of 
the included studies was made more reliable by employing a second rater to independently 
assess all the studies (Appendix B). Although the MQRS has been used in systematic reviews 
of RCTs for substance use, most recently (Li et al., 2017), one of the assessment domains 
(i.e., "Collaterals") did not apply to any of the studies in this review, which artificially 
increased their overall risk of bias.  
This review restricted the search parameters to randomised controlled trials (RCTs), 
which offer one of the highest levels of quality for research evidence (Boland et al., 2017).  
However, the results of this systematic review should be interpreted with caution due to 
potential biases introduced by the inclusion and exclusion criteria used to select the studies. 
The validity of the current review may have been limited by restricting searches to English 
language, published, peer-reviewed articles, and excluding grey literature. This approach 
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may have resulted in a reporting bias due to the potential for significant findings to be more 
likely published and translated into English (Boland et al., 2017). The search could have been 
extended to Latin American and Caribbean Health Sciences Literature (LILACS) to potentially 
minimise some of this risk. This database regularly publishes articles written in non-English 
languages. However, due to the time constraints of this study, and the researcher not able 
to read them without translation, this option was not taken up. 
In addition, the methodological limitations as identified in the quality assessment 
using the MQRS may also increase the risk of bias (Appendix C). Most of the studies had 
small samples, limiting the statistical power to detect treatment effects. Furthermore, 
methodological limitations such as nonprobability sampling might have led to limited 
generalisability, and self-report measures may bias results towards social desirability. 
Although two of the studies followed treatment participants for 12-month posttreatment or 
longer (Carrico et al., 2019; Chen et al., 2019), most studies only assessed treatment 
outcomes at posttreatment or 3 months after treatment completion. Notably, most 
mindfulness interventions adapted manualised protocols, with some not reporting 
treatment fidelity assessment (Foroushani, 2019; Yaghubi & Zargar, 2018). Failure to 
implement a protocol as planned increases the risk of a Type III error, whereby the observed 
findings are attributed to the methodological underpinnings of the intervention, ignoring the 
impact of the deviations from the protocol (Dusenbury et al., 2003). An evaluation of fidelity 
is important as it enables researchers to identify the changes made to the protocol and how 
those changes may have impacted the outcomes.  
Another limitation of the study is that different instruments were used to measure 
levels of substance craving for the meta-analysis. The studies included in the meta-analysis 
reported using empirically supported valid and reliable measures, all measuring the same 
underlying construct, substance craving. However, pooling the results from trials using 
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different instruments should be treated cautiously, as the measures may have different 
degrees of responsiveness, which can generate substantial heterogeneity (Puhan et al., 
2006). 
Despite its limitations, this review suggests that mindfulness-based treatments are a 
promising intervention for illicit substance misuse and relapse prevention in men. MBIs were 
also shown to improve other psychological outcomes associated with substance use. Meta-
analytic results reveal small-to-large effects sizes of mindfulness treatment in reducing levels 
of substance craving compared to treatment as usual or neutral attention control 
conditions. Future research would need to address the methodological concerns to further 
the empirical evidence for mindfulness-based interventions for substance misuse problems 
in men. This would require RCTs with larger sample sizes, evaluating treatments across a 
range of diverse populations and settings. Future studies should provide more detailed 
descriptions of the adapted protocols, randomisation protocols, and treatment fidelity and 
adherence due to variations in the interventions evaluated.  Although some methodological 
limitations have been reported, it appears that further research into MBIs as an intervention 
for substance misuse difficulties is warranted. Future studies should involve longitudinal and 
experimental designs with longer-term follow-up assessments to explore efficacy and 





III. Correlates of chemsex: Shame, mindfulness, sexual satisfaction, and self-efficacy beliefs 




Men who have sex with men (MSM) often experience high levels of shame and stress and 
low levels of sexual satisfaction. MSM are also at higher risk of maladaptive sexual 
behaviours such as risky and unprotected sex and polysubstance drug use (Evers, 2020). In 
recent years services have reported an increase in the demand for support with a form of 
sexualised drug use, known as chemsex. Although chemsex is highly prevalent in MSM, the 
majority report that it positively impacts their lives. However, some MSM struggle to re-
engage with ‘sober sex’. Sober sex is defined as the ability to have and enjoy sex without 
alcohol or drugs. The demand for support for problematic chemsex use has increased in 
recent years, but there are currently no specific theory or data-driven interventions. The 
potential mechanisms resulting in chemsex use or barriers to re-engaging in sober sex are 
not fully understood. There is growing evidence for mindfulness-based interventions in 
sexual problems and substance use, but this research has not been extended to those who 
engage in chemsex.  Here, we explore possible mechanisms behind the associations 
between shame, stress, sexual satisfaction, self-efficacy beliefs in engaging in sober sex and 
mindfulness. Cross-sectional survey data (n = 213) gathered in the study was collected from 
participants primarily through geospatial dating apps. Tests of difference found that MSM 
who report that chemsex has a negative impact on their life had significantly higher levels of 
shame and stress and lower levels of mindfulness, sexual satisfaction, and self-efficacy. 
Correlational analyses confirmed that shame and stress were strongly associated with each 
other, but both were negatively related to mindfulness, sexual satisfaction, and self-efficacy. 
Mindfulness was positively correlated with both sexual satisfaction and self-efficacy.  
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Mediation analyses were employed to address whether mindfulness statistically mediated 
the relationships between shame and sexual satisfaction and shame and self-efficacy. As 
measured by the Five-Facet Mindfulness Questionnaire, three facets of mindfulness had an 
association to the relationship between shame and sexual satisfaction (i.e., describe, acting 
with awareness and nonreactivity). It was also found that all five facets of mindfulness 
statistically partially mediated the association between shame and self-efficacy for initiating 
sober sex. These findings suggested a potential direction for future research targeting 
specific mindfulness facets in developing interventions for chemsex.  
 

































Sexualised drug use (SDU) refers to drug use before or during sex to enhance and 
prolong the sexual experience (Rosińska et al., 2018). A subset of SDU, chemsex, is a 
relatively recent phenomenon and is considered distinct from traditional sexual and 
substance misuse difficulties due to the drugs’ specificity and the context of its use. There is 
no global consensus on the definition of chemsex (Torres et al., 2020). It is subject to the 
availability of illicit drugs among subcultures within countries (Maxwell et al., 2019). 
However, in the UK, the drugs most commonly associated with chemsex are 
methamphetamine, g-hydroxybutyrate (GHB) and mephedrone (Bourne et al., 2014). The 
drugs, often taken in combination, facilitate the sexual experience by increasing arousal and 
lowering inhibitions whilst inducing an immediate sense of connection and intimacy with 
sexual partners (Smith & Tasker, 2018). Chemsex events, also known as “chill out parties”, 
may last several days involving multiple partners (Platteau et al., 2020) 
Chemsex is predominately associated with men who have sex with men (MSM). In 
the UK, chemsex amongst MSM is more prevalent than in the general population, with 
recent research suggesting that 6.6% of MSM in England had engaged in chemsex in the last 
four weeks, rising to 21.9% for those living with HIV (Bourne et al., 2014). However, media 
representations of chemsex are often sensationalist and damaging, focusing on the negative 
impact of problematic chemsex engagement among MSM (Aldridge, 2020).  This has had the 
effect of problematising substance use, regardless of the level of consumption, generating 
‘moral panic’ (Santoro et al., 2020) and pathologising people who engage in chemsex non-
problematically. There is not only a risk of further stigmatising MSM but complicating the 
development of appropriate public health responses (Pienaar et al., 2018). 
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However, there is no sophisticated understanding of the prevalence of drivers for 
chemsex (ACON, 2013b). NHS Trusts do not consistently collect chemsex prevalence data 
among MSM in any UK national surveillance systems, with most available data being almost 
exclusively sourced from sexual health and drug clinics in metropolitan areas (Edmundson et 
al., 2018). Qualitative evidence consistently suggests that MSM engaged in chemsex initially 
access services when there is an urgent sexual health need, such as testing for sexually 
transmitted infections (STI) or post-exposure prophylaxis (PEP) following potential exposure 
to HIV. Most MSM engaged in chemsex do not initially seek support for drug-related 
difficulties (Hegazi et al., 2017). Some anecdotal reports indicate that engagement in 
chemsex, alongside an increasing demand for help, is becoming more common across the 
UK, resulting in calls for a national targeted sexual health response (Moncrief, 2014).  
Many MSM who engage in chemsex consider sober sexual intimacy to be ‘normal’ or 
more authentic (Aldridge, 2020) and often report dissatisfaction with their reliance on drugs 
to enjoy sex. Individuals are increasingly seeking support to re-engage in ‘sober sex’, 
whereby they be “present” during sex without drugs being involved, and the connection 
between body and mind is maintained. Still, relapse is common (Kunelaki, 2019). However, 
the prevalence of chemsex among MSM, and the heightened pleasures associated with it, 
sexualised drug use can be challenging to disengage from (Moncrief, 2014). 
Given the increased demand for support from the chemsex community and high 
relapse rates, there has been a growing need to understand the factors underlying the 
behaviours maintaining chemsex engagement and ultimately developing targeted 
treatments specifically for the chemsex community. This is particularly important as 
problematic chemsex use has been associated with significant physical and mental health 
implications (Smith & Tasker, 2018) and is often riskier than “sober sex”. For example, there 
is an increased prevalence of unprotected sex in those who engage in chemsex (Bourne et 
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al., 2015). However, there is a lack of evidence about good practice in drug treatment for 
MSM service users, with limited studies measuring outcomes or evaluating service use by 
sexual orientation or gender identity (Williams et al., 2010). Part of the challenge of 
understanding chemsex use and ultimately developing treatments is that illicit drug users 
are often hard-to-reach populations, impacting recruitment into research studies (Cave et 
al., 2009). 
Without specific theory-driven or data-driven interventions for chemsex, many 
services support those seeking treatment by employing traditional substance misuse 
interventions to address substance use and sexual risk jointly (e.g., motivational interviewing 
and brief short-term structured behavioural change interventions; Moncrief, 2014). Some 
third sector organisations also offer group psychosocial treatments such as mindfulness 
interventions (e.g., Spectra; Hoff et al., 2020).  
With the limited evidence-based research, this study aims to explore possible 
factors theorised to be implicated in the maintenance of chemsex behaviours. It is hoped 
that it would provide additional data that could be used to build on the theoretical 
understandings of chemsex and guide intervention development. 
 
Internalised homophobia amongst men who have sex with men (MSM) 
In its report on sexual health, the World Health Organisation defined sexual well-
being as requiring a positive approach to sexuality and sexual relationships, not just as the 
absence of disease or dysfunction (WHO, 2006a). Individuals’ sexual health and well-being 
include sexual function, comfort and satisfaction (Douglas & Fenton, 2013), the ability to 
have pleasurable and safe sexual experiences, free from discrimination. 
However, 70% of the world’s population live under laws that limit freedom of 
expression of sexual orientation; in over 70 countries globally, same-sex relationships are 
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still illegal, for which the punishment is death in fourteen (Carroll & Mendos, 2017). Even in 
Great Britain, a country with laws protecting sexual minority groups, one in five LGBT people 
has experienced a hate crime because of their sexual orientation, with four in five anti-LGBT 
incidents estimated to go unreported (Bachmann & Gooch, 2017). Homonegative abuse 
occurs across the life span, with most sexual minority schoolchildren reporting being bullied 
through sexual orientation labelling (Stonewall, 2017).  
Perceived stigmatisation of one’s sexual minority identity can have lasting 
implications across the life span. As adults, 29% of LGBT  people avoid certain streets as they 
feel unsafe and, more than 58% of men who have sex with men (MSM) feel they cannot hold 
their partner’s hand in public without experiencing homophobic abuse (Bachmann & Gooch, 
2017).  
The concept of minority stress originates from social and psychological theoretical 
orientations. It is described as the relationship between minority and dominant societal 
values and the conflict with the prevailing social-cultural climate experienced by minority 
group members (Meyer, 2003). Many MSM internalise prevalent negative social attitudes in 
response to direct and implicit prejudice (Todd, 2016). Referred to as internalised 
homophobia, many MSM have negative feelings about themselves that originate from 
experiencing others as critical and rejecting. MSM can become highly critical of themselves, 
developing feelings of shame. Shame is a multi-faceted emotion associated with feelings of 
inferiority and defectiveness. Many individuals with high levels of shame desire to escape, 
hide or conceal perceived deficiencies (Irons & Lad, 2014). High levels of shame are 
associated with increased distress and other psychopathological symptoms (Gilbert, 1998). 
MSM can be exposed to many negative life experiences, such as rejection, social isolation 
and abuse (Morris, 2019),  and often present with higher levels of shame and elevated stress 
due to heightened vigilance related to these expectations (Meyer, 2003; Todd, 2016). Also, 
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MSM often experience a higher prevalence of depressive symptoms than the general 
population (Cho & Sohn, 2017). It has been estimated that the prevalence of depressive 
symptoms among MSM ranges from 29.2–63.9%, while the prevalence in the general 
population was 5.3–23.0% (Wang et al., 2017). Depressive symptoms, in turn, are also 
closely associated with increased risk for substance use (Wong et al., 2014) and risky sexual 
behaviours (Fendrich et al., 2013). Overall, MSM have a greater likelihood than the general 
population for risk-taking behaviours, including unprotected sex and polysubstance use 
(Kashubeck-West & Szymanski, 2008). 
Shame and related mental health difficulties are thought to be significant risk factors 
for poor sexual health in MSM for several reasons (Jaspal & Dhairyawan, 2018). Internalised 
homophobia is significantly and negatively correlated with self-esteem, precluding the 
desire to engage with safer sex behaviours (Kashubeck-West & Szymanski, 2008). Shame is 
also associated with maladaptive coping strategies such as alcohol and substance misuse 
and can negatively impact an individual’s desire for intimacy or their ability to connect with 
others (Jaspal, 2018). Shame also often exacerbates social disconnections, where people 
withdraw or avoid others and their communities, ultimately generating a sense of loneliness 
(Hartling et al., 2004). For example, if MSM feel negatively about engaging in sexual 
activities, because of perceived societal disapproval, they experience lower levels of 
enjoyment, which is theorised to reduce their desire to seek out same-sex partners (Li et al., 
2019). Poor relational factors and low intimacy are a strong predictor of poor overall sexual 
satisfaction and sexual well-being in heterosexual and homosexual men (Carvalheira & 
Costa, 2015). Research also suggests that levels of shame and distress levels are particularly 
high within MSM who engage in chemsex, and these are hypothesised to act as barriers to 
re-initiating sober sex (Morris, 2019). Extensions in the development of  Compassion 
Focused Therapy (CFT; Gilbert, 2014) in the field of psychosexual difficulties may provide 
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support for those experiencing high levels of shame, which may play a role in the 
maintenance of sexual problems (Vosper et al., 2021). 
 
MSM and chemsex / ‘sober sex’ 
Drug consumption amongst gay men in sexual contexts has been a part of queer 
culture for a long time (Florêncio, 2021). However, when The Chemsex Study (Bourne et al., 
2014) was published, a survey commissioned to understand the prevalence of chemsex in 
the London boroughs of Lambeth, Southwark and Lewisham, many news outlets created a 
narrative about the gay community in London self-medicating their shame (Florêncio, 2021). 
The consequences were to further alienate a community already stigmatised by legal and 
public health responses to drugs and sex (Frederick & Perrone, 2014). 
Whilst it is common to view the chemsex experience through a lens of health risks to 
inform health care planning, it is important to note that many within the chemsex 
community rarely see themselves as having difficulties with drugs. Many MSM who engage 
with chemsex do not consider themselves drug users or relate to other drug users’ 
experiences (Evans, 2019). The majority of MSM feel in control of their chemsex 
engagement and derive pleasure from it with few negative consequences (Platteau et al., 
2019). 
Previous research has found that there are various motivations why MSM begin 
engaging in chemsex. Weatherburn et al. (2017) found two distinct clusters of motivations. 
Firstly, chemsex enables the individual to have the type of sex that they want and, secondly, 
the drugs enhancing the qualities they want in sex. Additional reasons identified were 
facilitating a sense of belonging and increasing the ability to cope with everyday problems 
both thought to facilitate substance use (Milhet et al., 2019). However, this stage in the 
chemsex journey is under-researched (Platteau et al., 2020), potentially impacting the 
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development of appropriate care and support for those engaging in non-problematic 
chemsex. 
However, chemsex use can become problematic, although what this means is not 
consistently defined, and the mechanisms for change are currently unknown (Platteau et al., 
2019). The continuum perspective of chemsex has emerged in the last two years, presenting 
chemsex engagement as a journey from non-problematic towards problematic use for some; 
a process named spiralling (Platteau et al., 2020). Problematic use is loosely defined as when 
individuals experience one or more unwanted outcomes (Platteau et al., 2020). 
The continuum approach to chemsex suggests that there may be opportunities to 
support people at earlier stages of drug use to prevent or reduce problems at later stages. It 
is a potential starting point to build the evidence base and better understand the chemsex 
journey's mechanisms (Platteau et al., 2019).  
Many MSM currently seeking support do so from sexual health services and typically 
describe the journey from exciting and hedonistic drug use to a high-risk activity (Smith & 
Tasker, 2018). Users report deteriorating physical and mental health, loss of friends and 
employment, addiction, overdose, and sexual assault (Hockenhull et al., 2017). The 
increased prevalence of sexual assault amongst those who engage in chemsex primarily 
occurs when an individual loses their capacity to consent to sex when under the influence of 
the drugs. Research suggests that problematic chemsex use is strongly correlated with 
higher-risk sexual behaviour (e.g., unprotected sex) and may facilitate STI transmission 
(Tomkins et al., 2019). Some MSM inject drugs in the context of chemsex. This is known as 
“slamming” or “slamsex”. Those who engage in slamming and share needles, also have an 
increased risk of exposure to blood-borne viruses such as hepatitis, syphilis or HIV (Lafortune 
et al., 2021). Those who engage with problematic chemsex are reported to access with 
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sexual health services more frequently and have more regular STI testing than those who do 
not (Blomquist et al., 2020).  
Most research on chemsex has focused on clinical populations and those actively 
seeking support (Aldridge, 2020). There is, therefore, a gap in the literature exploring the 
experiences of those who report a positive engagement with chemsex, and not accessing 
services for support. It is hoped that this study will expand the evidence base to include 
those with positive and negative chemsex experiences to raise awareness of the different 
chemsex trajectories. It is hoped that understanding the potential mechanisms underlying 
the chemsex journey would support the growing evidence base to develop theory-, or data-, 
driven interventions for those looking to re-engage in sober sex. 
 
Self-Efficacy Beliefs in initiating Sober Sex 
Many MSM who engage in chemsex report sober sexual intimacy to be ‘more 
authentic’ or a social ideal compared to sex under the influence of drugs. (Aldridge, 2020). 
Consequently, many MSM report dissatisfaction with their reliance on drugs to enjoy sex, 
which is experienced as self-stigmatising and undermines their sexual well-being (Milhet et 
al., 2019). 
Whilst research consistently reports that chemsex is associated with an increase in 
sexual functioning, sexual pleasure and satisfaction (Lafortune et al., 2021), it is also 
associated with a lower sexual self-efficacy. This relates to people’s beliefs in their ability to 
perform sexually (Hibbert et al., 2019; Voisin et al., 2017). Although these results appear to 
contradict each other, they could also be interpreted that engaging in chemsex is a 
mechanism with which to overcome pre-existing difficulties with sexual well-being, such as 
sexual self-efficacy (Lafortune et al., 2021). The presence of lower sexual self-efficacy is 
theorised to drive the use of chemsex drugs which may boost an individual’s self-confidence 
to engage in sex (Hibbert et al., 2019; Voisin et al., 2017). 
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Not only is lower sexual self-efficacy thought to be a potential motivator to engage 
in chemsex, but research into traditional substance misuse indicates that low self-efficacy 
beliefs in abstinence are one of the strongest indicators of substance relapse (Nikmanesh et 
al., 2016). Models of behaviour change often emphasise the importance of self-efficacy in 
influencing behaviour change (Jaspal, 2018). Specific behaviour models include the Theory of 
Planned Behaviour (Ajzen, 1985) and the Social Cognitive Theory (Bandura, 1986), and 
research has found associations between chemsex engagement and constructs from these 
models (Evers et al., 2020).  
Traditional substance misuse theories focus on self-efficacy in its importance in 
predicting drug use related behaviour (West & Brown, 2013). Theories such as these suggest 
that personal factors, such as perceived self-efficacy, are highly influential in determining 
whether a behaviour is likely to be enacted or not. For example, an individual’s belief in 
whether they can engage in sober sex would be theorised to partially determine whether 
they do engage in sober sex. According to Bandura, personal factors (e.g., self-efficacy) 
interacting with external social, environmental factors (e.g., social norms) are central to 
facilitating the behaviour. However, most MSM who engage in chemsex indicate that they 
have confidence they can refuse drugs before or during sex when they do not want to use 
them (Evers et al., 2020). As such, enhanced self-efficacy may have a slightly different 
consequence in MSM who engage in chemsex. Higher self-efficacy beliefs to have sober sex 
in this context impacts their sexual well-being as they don’t feel that they are “trapped” 
within a cycle of substance use and feel they can choose to have sex without drugs. The self-
efficacy beliefs that they can choose to have sex without drugs may be associated with 
greater sexual well-being. This study investigates chemsex from a positive approach to 
sexuality and sexual relationships. As such, the primary focus of this study is not considering 
self-efficacy to engage in sober sex as a predictor of substance relapse. Instead, this study 
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takes a more nuanced approach, focusing on perceived self-efficacy beliefs as influencing 
sexual well-being where individuals are “not feeling addicted”, and are able to enjoy sober 
sex. 
 
Mindfulness, shame, substance use and sex 
Previous research suggests that there is a negative association between shame and 
mindfulness (Sedighimornani et al., 2019). This supports the assumption that shame is an 
emotional state associated with higher levels of self-conscious thoughts (Bishop et al., 2004), 
and lower levels of experiential objectivity (Joireman, 2004). Consequently, mindfulness 
might be related to shame as a strategy in which to offset negative emotional states 
(Sedighimornani et al., 2019).  
Mindfulness-based interventions have been the focus of much research across a 
range of presentations, including substance use and sexual difficulties (Brem et al., 2017). 
For this study, dispositional mindfulness is defined as the individual’s ability to purposefully 
bring attention and awareness to the present moment’s experiences and relate to them in a 
non-judgmental way (Chiesa, 2017). It has been suggested that having the capacity to 
engage with thoughts and experiences without reactivity or judgment may contribute to 
mindfulness’s effectiveness as an intervention for a range of difficulties that involve poor 
impulse control, such as substance use and sexual behaviours (Brem et al., 2017).   
A neurocognitive model developed by (Garland, Froeliger, et al., 2014) hypothesised 
that individuals with substance use difficulties could not control cognitive and emotional 
responses to cues and stresses that trigger craving and substance use (Enkema et al., 2020). 
The authors suggested a potential mechanism by which mindfulness interventions target 
cognitive, affective, and neurobiological systems that have been affected by repeated drug 
use, thereby reducing the risk of relapse. 
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Emerging research suggests that training people to practise mindfulness, even brief 
interventions, is related to a decreased use of substances and a decreased likelihood of 
relapse (Enkema et al., 2020). Studies into the efficacy of mindfulness-based relapse 
prevention (MBRP) interventions have consistently shown a positive effect of mindfulness 
on craving and substance use (Abed & Shahidi, 2019). A recent meta-analysis (Karyadi et al., 
2014b) found evidence for a significant but inverse relationship between overall 
dispositional mindfulness and substance use. This relationship was more robust for 
individuals with more problematic substance use. Another recent meta-analysis indicates 
that increased mindfulness practice has also been shown to reduce anxiety, depression, and 
experiential avoidance  (Vadivale & Sathiyaseelan, 2019). 
Mindfulness may also contribute to healthy sexual well-being outcomes. Research 
amongst heterosexual populations has found mindfulness is also related to problematic 
sexual behaviours. Increases in dispositional mindfulness were shown to be related to 
increases in sexual self-control and reductions in relationship and affect disturbance, and 
sexual preoccupation (Shorey et al., 2016). In addition, research has also found that 
mindfulness may enable better emotion regulation and more intentional behaviour (Leavitt 
et al., 2019) and is associated with a reduction in overall sexual difficulties (Brotto et al., 
2016). Together, these results suggest that mindfulness may be an important in difficulties 
relating to sexual well-being. 
However, it is not known whether these results are generalisable outside of the 
heterosexual populations studied. Although no studies to date have extended this research 
to MSM engaged with chemsex, third sector support organisations (e.g. Spectra - London) 
have already begun to successfully use mindfulness-based interventions for those who 
struggle to re-engage with sober sex (Hoff et al., 2020). 
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In additional to being related to positive substance use and sexual well-being 
outcomes, previous research on the interaction between mindfulness and self-efficacy in 
substance misuse populations suggests they both have an important role in coping with 
stress, promoting positive affect, increased satisfaction with life and self-esteem. However, 
the results have been mixed and suggest that mindfulness may increase self-efficacy in the 
short term but not necessarily in the long term (Firth et al., 2019). This supports the need for 
continued research and development of theory and data-driven models and interventions 
(Vosper et al., 2021). 
As discussed, previous research suggests that a negative association between shame 
and mindfulness, and that higher levels of shame are associated with lower levels of sexual 
satisfaction and self-efficacy beliefs. As MBIs have been shown have a positive impact on 
both sexual wellbeing and self-efficacy beliefs, it is not unreasonable to assume that 
mindfulness potentially mediates the effect of shame. However, to the author’s knowledge, 
there have been no studies published that explores this potential mediation mechanism in 
MSM who engage in chemsex. 
 
Current Study 
Whilst it is recognised that some people who engage in chemsex report that it has a 
positive impact on their lives, some people develop problematic drug use. It is hoped that 
this study will increase the evidence base associated with chemsex, moving away from the 
sole focus of problematic drug use, and creating a narrative for all those engaged in 
chemsex.  
In healthcare settings, specific support services for people engaging in chemsex are 
uncommon (Platteau et al., 2020). It has been reported that people engaging in chemsex 
looking for support are commonly signposted between the current provisions developed for 
‘traditional’ drug services and sexual health care (McCall et al., 2015). However,  few of 
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these services provide empirically supported intervention programs for chemsex (Graf et al., 
2018). In the absence of a theory-driven intervention, many MSM who engage in 
problematic chemsex fall between the cracks in existing services and, most concerningly, are 
not able to access support when they need it (Platteau et al., 2020) 
This study hopes to extend previous research by exploring the associations between 
shame and sexual satisfaction with self-efficacy for initiating sober sex and mindfulness in 
MSM who engage in chemsex. It is hypothesised that: 
I.those disclosing problematic chemsex use will have higher levels of shame and stress 
and lower levels of sexual satisfaction and self-efficacy in initiating sober sex 
II.shame is negatively related to sexual satisfaction and self-efficacy for initiating sober 
sex but positively associated with increased levels of distress 
III.mindfulness is positively related to sexual satisfaction and self-efficacy for initiating 
sober sex but negatively associated with levels of shame and distress and 
IV.there is a mediation effect of mindfulness between shame and sexual satisfaction and 
shame and self-efficacy for initiating sober sex. 
While most research has been focused on heterosexual populations, the evidence 
base for MSM is growing. However, as there is currently no evidence about mindfulness in 
MSM who engage in chemsex, this study is hoped to provide support for the development of 




Materials and Methods 
 
Collaboration with Experts by Experience (EBEs). 
The implementation strategy for this project was created in collaboration with two 
experts by experience (EBEs) and a specialist clinician. The EBEs were recruited from a club 
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drug clinic and have had previous experience contributing to focus groups and small-scale 
service development projects. The EBEs were involved in all stages of the study, shaping its 
design, including the development of the novel measure, and aiding in interpreting results. 
The EBEs piloted this study during the first national lockdown that was enacted to reduce 
the Coronavirus transmission. The experts by experience (EBEs) recommended adding two 
additional questions in the questionnaire in response to potential changes in chemsex 
engagement during the lockdown. The first was to add “video platform” to the list of 
contexts in which chemsex occurs. This was in response to anecdotal reports that chemsex 
parties were moving online. The second was whether the “Impact of the Coronavirus 
pandemic on chemsex engagement” had increased, decreased, or remained the same. 
 
Participants and sampling. 
Inclusion criteria for the study were men over the age of 18 living in Great Britain 
who self-reported having sex with other men and who engaged in chemsex within the 
previous 12 months. Any incomplete answers (i.e., those who completed less than 50% of 
the survey) were excluded. The study was advertised through the social media accounts of 
third sector LGBT support organisations and via internet message boards and geospatial 
dating apps. Geospatial dating apps are a particularly appropriate platform. Some are known 
to be one of the primary vectors through which chemsex drugs are procured and “chill out 
parties” are organised (Ahmed et al., 2016). Dating apps allow MSM to quickly and 
anonymously align their specific desires and practices with others with similar interests (de 
Sousa et al., 2020). It also provides researchers access to participants of diverse 
characteristics and backgrounds (Koc, 2016). 
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Characteristics of the study sample. 
A total of 213 participants completed the survey. The mean age (SD) of the sample was 
38.55 years (±10.43 years), with more than 73% of the sample aged 30 years or older. 
Almost 89% of the participants identified as White British or White European, with only 11% 
identifying as non-White or mixed ethnicity. More than 96% identified as male, and most 
MSM identified as gay or bisexual (95%). 66% of participants reported that they were HIV-
Negative (when last tested). Full details of the demographic characteristics of the sample are 
summarised in Table 4. 
 
Table 4 
Socio-demographic Characteristics of the Study Sample 
Variable Category N % 
Age 
18 - 29 56 26.3 
30 – 44 88 41.3 
45 – 59 67 31.5 
60+ 1 0.5 
Ethnicity 
White British 151 70.9 
Other White European 38 17.8 
Mixed 6 2.8 
Asian or Asian British 6 2.8 
Black or Black British 8 3.8 
Other Ethnic groups 4 1.9 
Gender 
Male 205 96.2 
Non-binary 4 1.9 
Trans 1 0.5 
Other 2 0.9 
Sexuality 
Gay 176 82.6 
Bisexual 27 12.7 
Straight 2 0.9 
Pansexual 5 2.3 
Other 3 1.4 
HIV 
Status 
HIV Positive 69 32.4 
HIV Negative (when last tested) 141 66.2 




Ethical approval for this research was granted by the London Bromley Research 
Ethics Committee on 16/10/20 (Appendix D), and approval was received from the HRA and 
Health Care Research Wales (HCRW) on 21/10/20 (Appendix E). Ethical approval was also 
obtained from Royal Holloway, University of London, on 10/11/2020 (Appendix F). 
The study was an exploratory, cross-sectional survey design with participants 
recruited between November 2020 and February 2021 throughout the UK. A trainee clinical 
psychologist was responsible for coordinating the recruitment activity and monitoring the 
survey data collection. With the help of LGBT support organisations participants were 
recruited through internet publicity, peer recommendation, and outreach activities. Also, 
direct recruitment through online sources (e.g., Facebook, Reddit, Instagram, Twitter, Grindr 
etc.) was facilitated by the researcher. It was hoped recruitment would also include service 
users under the care of NHS sexual health services. However, due to the nationwide 
lockdowns necessitated by the Coronavirus pandemic, many services reverted to remote 
working, and service user contact was significantly reduced. As such, it was not possible to 
recruit participants from NHS services directly.  
Participants recruited directly through social media and geospatial dating apps could 
access the questionnaires hosted on a commercial survey website through embedded 
hyperlinks/QR Codes in the study information. To ensure participant anonymity, neither IP 
addresses nor respondent location data were recorded. After reading the study information 
and consenting, participants completed online measures and demographic information and 
information relating to their engagement in chemsex.  The entire test battery took 
approximately fifteen minutes and was piloted by experts by experience to test feasibility 
before going live.  
Participation levels were closely monitored throughout the project, and as soon as 
the recruitment target was reached, recruitment was ended, accommodating for missing 
 61 
data. Of the 242 participants who began the survey, 213 met the inclusion criteria and 
completed at least 50% of the measures (completion rate: 87.6%) and were included in the 
final analysis.   
 
Power 
Power was calculated for the first hypothesis, exploring differences between those 
engaged in non-problematic versus problematic chemsex, using G*Power 3.1 (Faul et al., 
2009). Based on prior research by Luoma et al., (2019) an alpha level of 0.05 and power set 
at 0.8 (Cohen, 1988), a total sample size of 84 was indicated for a two-tailed t-test model. 
Power was also calculated for the correlational research hypotheses using a Correlational 
Sample Size Calculator (Hulley et al., 2013). Šević et al. (2016) indicated that for the 
associations between shame, mindfulness and sexual satisfaction, a medium correlation 
coefficient is expected. Based on an alpha level of 0.05 and power set at 0.8 (Cohen, 1988), a 
total sample size of 30-50 is indicated for a two-tailed correlational model. Finally, power 
was calculated for the mediation analysis using a Monte Carlo Power Analysis for Indirect 
Effects (Schoemann et al., 2017). Based on previous research assessing the mediating 
influence of mindfulness on sexual satisfaction, a medium effect size was expected (Dunkley 
et al., 2015). Based on an alpha level of 0.05 and power at 0.8 (Cohen, 1988), a total sample 
size of 200 is indicated for a one-tailed linear multiple regression model.  
To be sufficiently powered to conduct the analyses required for the study’s 
hypotheses, a total recruitment target of 250 was set. Survey completion rates were 






Demographic variables in the study were: age (in years), ethnicity (white British, 
other white European, Mixed, Asian or Asian British, Black or Black British, other ethnic 
groups), gender identification (male, non-binary, trans or other), sexual orientation (gay, 
bisexual, straight, pansexual, asexual or other) and HIV Status (HIV Positive, HIV Negative or 
unsure). 
Chemsex-related characteristics. 
This section of the survey was created in collaboration with the experts by 
experience and a specialist clinician. The variables were; chemsex drugs used (G [GHB/GBL], 
T [Tina / Crystal Meth], M [M-cat, Mephedrone] or Other), frequency of chemsex in the last 
12 months (none, once, two to five times, six to ten times or eleven or more times), location 
of chemsex use (chill-out party, home, sex venue, video platform, nightclub/bar, cruising 
area or other), impact on well-being (positive, negative, no impact or unsure), feeling in 
control of chemsex use (yes/no/unsure), ever considered support for chemsex? 
(yes/no/unsure), the impact of coronavirus pandemic on chemsex engagement (increased, 
decreased, remained the same or unsure).   
 
Depression, Anxiety and Stress Scale – Short Form (DASS-21). 
Levels of emotional distress were measured using the short form Depression, 
Anxiety and Stress Scale (Lovibond & Lovibond, 1995) (Appendix N). This 21-item shortened 
version of the long-form Depression, Anxiety and Stress Scale (DASS-42) consists of three 
subscales measuring depression, anxiety and stress. Participants rated how much each 
statement applied to them over the past week on a four-point Likert scale 0–3. (0 = Did not 
apply to me at all, 3 = Applied to me very much or most of the time). Statements include 'I 
was aware of dryness of my mouth', 'I tended to over-react to situations' and 'I couldn't 
 63 
seem to experience any positive feeling at all'. Higher scores indicated higher levels of stress, 
anxiety and depressive symptoms. The DASS-21 subscales have Cronbach's alphas of 0.94 for 
depression, 0.87 for anxiety and 0.91 for stress (Antony & Bieling, 1998), and moderate 
levels of concurrent validity (Antony & Bieling, 1998).  
This study focused on the stress subscale as prior research suggests this shows the 
greatest levels of clinically significant change between problematic and non-problematic 
stages of substance use (Ronk et al., 2013). In addition, research also indicates that in 
substance-using and risk-taking populations, men's level of stress is significantly different to 
that of women. In contrast, no gender differences were found in the depression and anxiety 
subscales (de Haan et al., 2015).    
 
Internalised Shame Scale (ISS). 
Levels of Internalised Shame were measured using the Internalised Shame Scale – 
ISS;  Cook, 1987 (Appendix M). The ISS is a 30-item self-report inventory designed to 
measure trait shame in adolescents and adults. The ISS is a self-report measure that assesses 
trait shame, composed of an Internal Shame subscale, measuring internalised shame, and a 
Self-Esteem subscale. The Internal Shame and Self-Esteem subscales present as one-
dimensional structures. The subscales present high internal consistency, excellent temporal 
stability, Cronbach alpha for shame = 0.90, and self-esteem = 0.88 (del Rosario & White, 
2006). 
This study focused on the shame subscale due to the relatively high levels and 
temporal stability found within this population. It is a strong predictor of substance use and 
sexually risky behaviours (Morris, 2019).  
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Five-Facet Mindfulness Questionnaire-Short Form (FFMQ-SF). 
The current study uses the Five Facet Mindfulness Questionnaire (FFMQ-SF; 
(Bohlmeijer et al., 2011) to measure levels of mindfulness (Appendix P). Mindfulness being 
defined by the authors as the tendency to be mindful in daily life. The short-form of the 
instrument has been demonstrated to be sufficiently reliable and valid for research purposes 
and community samples, with all facets demonstrating Cronbach's alpha greater than 0.70 
(Iani et al., 2020).   
These five facets consist of observing, describing, acting with awareness, being non-
judgmental and nonreactivity to inner experience. The original developers of the FFMQ 
defined each facet as: 
i) Observing - noticing internal and external experiences, including cognitions, 
emotions, sights, sounds, and smells 
ii) Describing - being skilled at describing personal experiences with words 
iii) Acting with awareness - being attentive in one's approach to present-moment 
activities 
iv) Non-judgmental - approaching experiences without judgment, and 
v) Nonreactivity - not getting caught up by thoughts and experiences. 
 
Confirmatory factor analyses of the measure indicate that a hierarchical model, with 
the five facets loading onto a general factor of mindfulness, have good fit indices for the 
populations sampled (Christopher et al., 2012). However, most studies suggest that a five-
factor structure has better fit indices than a unidimensional general factor of mindfulness 
(Aguado et al., 2015). For this study, a unidimensional measure of mindfulness will be used 
in the initial exploratory analyses of this study's constructs of interest. However, as research 
suggests that deficits in each individual facet of mindfulness may play a contributory role in 
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substance use and relapse prediction (Levin et al., 2014), the mediation analyses will be 
conducted at the facet level.  
Observing, describing, and acting with awareness, are thought to be important in 
identifying triggers, which can inform effective coping strategies in the moment and reduce 
the potential for impulsively using substances in reaction to stimuli (Bowen et al., 2012). 
Those with a greater capacity to describe and better differentiate one's emotions 
throughout the day experience a reduced reliance on substance abuse, even when 
experiencing negative affect (Kashdan & Rottenberg, 2010). The individual facets of 
acceptance, awareness, and non-judgment were reported to significantly mediate the 
relationship between MBRP and self-reported substance cravings following the treatment 
programme (Witkiewitz et al., 2013). 
As substance use treatments informed by mindfulness are designed to develop 
multiple facets of mindfulness (Brem et al., 2017), identifying the most relevant mediating 
facets of mindfulness in MSM who engage in chemsex may indicate the cost-effective 
treatment approaches.  
Respondents answered questions according to a 5-point Likert scale ranging from 1 
"Never or very rarely true" to 5 "Very often or always true." The FFMQ has been shown to 
display good construct validity (Baer et al., 2008), test/re-test reliability (Isenberg, 2009), 
and internal consistency in both non-clinical (Baer et al., 2006) and clinical samples 
(Bohlmeijer et al., 2011). In Levin et al. (2014), each subscale demonstrated adequate 
internal consistency with the following Cronbach's alphas  (Observing 0.81; Describing 0.89; 
Acting with awareness 0.90; Non-judgmental 0.91; and Nonreactivity 0.81). 
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New Sexual Satisfaction Scale – Short Form (NSSS-SF). 
Sexual satisfaction was assessed using the short New Sexual Satisfaction Scale form 
(NSSS-SF), consisting of 12 items that indicate various facets of satisfaction with one's sex 
life (Brouillard et al., 2020) (Appendix O). More specifically, participants are asked to rate 
their satisfaction with "The balance between what I give and receive in sex," "The variety of 
my sexual activities," etc. Responses are anchored on a 5-point Likert-type scale. The NSSS-
SF has high internal consistency in (Cronbach's a=0.92 and 0.93). Higher scores denote 
greater sexual satisfaction. Convergent validity has been demonstrated by strong and 
significant associations between a global measure of sexual satisfaction and the NSSS-SF 
scores (Stulhofer et al., 2011). To assess the participant’s beliefs about sexual satisfaction 
without drugs, this measure specifically requested to answer concerning their satisfaction in 
sober sex. 
Self-efficacy In Initiating Sober Sex (SEISS). 
In early discussions with the EBEs, it became clear of the importance they felt that 
their beliefs in engaging in sober sex influenced whether they actually engaged in sober sex. 
Both EBEs reported that experiencing low self-efficacy beliefs in their sexual abilities was a 
barrier to engaging in sober sex. They also described that having low self-confidence in 
engaging in sober sex affected their sexual well-being, feeling “trapped” as they felt they 
could not enjoy sex without drugs. It was agreed that this was an important factor to 
explore, so, based upon their experiences, it was decided to include a self-efficacy measure 
in the study. 
The concept of self-efficacy is well established. It is defined as the belief in one's 
ability to engage in a behaviour (Bandura, 1986). Self-efficacy beliefs about a behaviour are 
highly predictive of whether an individual will engage in those behaviours. The higher the 
level of beliefs, the more likely the behaviour will be enacted. However, there is no all-
purpose measure of perceived self-efficacy, as people differ in their efficacy across different 
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domains. For example, an individual may have firm self-efficacy beliefs that they can drive a 
car but have lower beliefs to repair it.  
As such, it is not unusual for researchers to develop novel scales when investigating 
self-efficacy beliefs in specific areas. Based upon Bandura's guidelines for designing self-
efficacy measures (Bandura, 2006) and working closely with experts by experience, a novel 
scale was developed to measure self-efficacy beliefs in initiating sober sex. A step-by-step 
methodological approach to behaviour change was adopted, as suggested by self-efficacy 
literature (Bandura, 2006). Each step in the process of preparing to initiate sober sex is 
incremental, which may build confidence for the remaining steps. To create a novel scale to 
measure self-efficacy in engaging in sober sex, adaptations were made to existing scales 
developed for two Royal Holloway – University of London theses (Madden, 2018; 
Smallwood, 2020).  
In discussion with the EBEs, the common barriers to engaging in sober sex were 
identified. The original scale focused on broad barriers for engaging in sober sex (i.e., 
people's ability to be present and enjoy the experience, their confidence in performing 
sexually etc.). However, as the scale went through various iterations, the EBEs identified that 
the most common barriers to overcome were those associated with initiating sex.  It was 
decided that the scale should focus on those barriers to initiating sober sex that needed to 
be overcome. The new measure was named the "Self-efficacy in Initiating Sober Sex“ (SEISS) 
scale. 
As self-efficacy is a complex construct (Schwarzer & Renner, 2000), a multiple-item 
measure approach was agreed upon, which enabled more information to be captured than 
can be provided by a single-item measure. This enabled more of the potential facets of the 
construct of interest to be measured (Baumgartner & Homburg, 1996). The larger diversity 
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of total scores also makes it possible to make relatively fine distinctions among participants 
(Churchill, 1979). 
Participants were presented with items portraying different levels of task demands, 
rated based on the strength of their belief in their ability to execute the requisite activities. 
For this study, they record the strength of their efficacy beliefs on a 100-point scale, ranging 
in 100-unit intervals from 0 ("Cannot do"); to 100 ("Highly certain can do"). More 
specifically, participants are asked to rate the confidence with which they could initiate 
sober sex without necessitating alcohol or drugs (e.g., "I feel confident enough to consider 
having sexual contact with someone", "I am able to make advances towards an existing 
sexual partner," etc.). This novel measure has been replicated in Appendix Q. 
As this is a novel instrument, it was essential to validate the scale, and appropriate 
psychometrics are reported in detail within the results section. The psychometric analysis 
indicated a single-factor solution for this measure. A total score was computed, with higher 
scores indicating a firmer self-efficacy belief in initiating sober sex. 
   
Data analytic strategy. 
The following data analytic strategy was employed to explore the relationship 
between shame, dispositional mindfulness and sexual satisfaction/self-efficacy beliefs in 
initiating sober sex. SPSS v25.0 (IBM SPSS Statistics for Macintosh, 2017) was used to analyse 
the data. A missing data analysis was conducted on the outcome measures using Little's test 
(Little, 1988), which indicated that any data was missing completely at random. To preserve 
sample size, the discrete missing data values were estimated using an expectation 
maximisation technique. Comparisons of the outcome measure means before and after 
imputation were made, and no significant differences found.   
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Descriptive statistics were used to present the demographic and chemsex associated 
characteristics of the sample. Descriptive statistics of all the outcome measures (i.e., means 
and standard deviations) were then calculated. The normalities of the outcome variables 
were tested by calculating z-scores for skewness and kurtosis (Appendix S). The z-scores 
were all below the cut off of 3.29 (Kim, 2013), and the outcomes were deemed to be 
normally distributed. 
Whether or not outcomes differed between participants with positive or negative 
experiences of chemsex was evaluated using independent t-tests and chi-square tests of 
independence. Bivariate correlations among all study variables were determined using 
Pearson's correlation analysis to examine the relationships among stigma, levels of distress, 
the facets of mindfulness, sexual satisfaction and self-efficacy belief scales.  
To test the secondary hypotheses, a mediation modelling analysis was conducted 
using Hayes's PROCESS macro for SPSS (Hayes, 2014) to test the indirect effects of 
internalised shame on sexual satisfaction and self-efficacy beliefs in initiating sober sex 
through the facets of mindfulness. Shame was entered into the model as the independent 
variable. The five facets of mindfulness were entered separately as mediating variables, and 





Chemsex characteristics of the study sample 
Descriptive statistics on the study population’s chemsex characteristics are 
presented in Table 5. Most participants engaged in chemsex more than six times in the last 
12 months (82%), mainly at chemsex (chill out) parties (90%), using a combination of G 
[GHB/GBL] and T [Tina / Crystal Meth] (93%). Most felt that chemsex had a positive or 
neutral impact on their well-being (74%), felt in control of their substance use (76%), and 
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had not considered support for their substance use (70%). The recruitment study occurred 
during the Coronavirus pandemic, and most participants felt their chemsex engagement had 
increased or remained the same during this period (59%).  
 
Table 5 
Chemsex Characteristics of the Study Sample 
Variable Category N % 
Chemsex drugs used 
G [GHB/GBL] 207 97.2 
T [Tina / Crystal Meth] 200 93.9 
M [M-cat, Mephedrone] 69 32.4 
Other 81 38.0 
Frequency of Chemsex  
(in the last 12 months) 
Once 2 0.9 
Two to five times 34 16.0 
Six to ten times 73 34.3 
Eleven or more times 102 47.9 
Location 
Chemsex (chill out) Party 192 90.1 
Home (alone or with a partner) 126 59.2 
Sex Venue 14 6.6 
Video Platform 76 35.7 
Nightclub/bar 8 3.8 
Cruising area 32 15.0 
Other 41 19.2 
Impact on Well-being 
Positively 136 63.8 
Negatively 46 21.6 
No Impact 21 9.9 
Unsure 9 4.2 
Control of chems use 
Yes 162 76.1 
No 25 11.7 
Unsure 25 11.7 
Considered support for chemsex? 
Yes 57 26.8 
No  149 70.0 
Unsure 6 2.8 
Impact of Coronavirus pandemic on 
chemsex engagement 
Increased 46 21.6 
Decreased 84 39.4 
Remained the same 80 37.6 
Unsure 2 0.9 
 
 
Psychometrics of the novel Self Efficacy Beliefs in Initiating Sober Sex Scale (SEISS) 
Bivariate correlations were conducted to examine the relationships between the 
novel SEISS items (see Table 6). All items were significantly correlated in the expected 
direction (i.e., greater self-efficacy beliefs in initiating sober sex in one item was positively 
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related to self-efficacy beliefs in another). The correlation coefficients ranged from .50 to 
.94.  
Table 6 
Descriptive Statistics and Bivariate Correlations between the SEISS Items (n=213) 
Variable M ± SD 1 2 3 4 5 6 
1. Attractive 14.18 (9.34) -      
2. Contact 10.01 (8.95) .78*** -     
3. Approach Existing 11.70 (9.05) .54*** .67*** -    
4. Accept Existing 57.81 (20.95) .50*** .63*** .94*** -   
5. Approach New 18.67 (5.52) .64*** .70** .59*** .51*** -  
6. Accept New 14.34 (3.79) .64*** .73* .59** .58*** .88*** - 
*p<0.05 **p<0.01 ***p<0.001 
 
Internal consistency was assessed, the degree to which responses are consistent 
across items, using Cronbach’s Alpha. Commonly used guidelines suggest that the score of 
.920 indicated that the measure’s internal consistency was excellent/strong (Tavakol & 
Dennick, 2011). 
The suitability of the data for structure detection was tested using the Kaiser-Meyer-
Olkin Measure of Sampling Adequacy (KMO) and Bartlett’s test of sphericity. The KMO 
statistic (.743) indicated that the proportion of variance in the items might be caused by 
underlying factors, suggesting that a factor analysis may be indicated (Field, 2017). Bartlett’s 
test of sphericity was significant (<.001), indicating that the item variables are related and 
suitable for structure detection (Field, 2017). 
An exploratory factor analysis was conducted to assess sources of common variation 
within underlying structures within the data (Carpenter, 2018).  As the data was normally 
distributed, the maximum likelihood extraction method was selected (Fabrigar et al., 1999). 
A scree plot of the eigenvalues derived from the resulting factors shows that a single factor 
solution containing all six items was indicated (Appendix R), confirmed by the principal 
component analysis (Appendix R). The other analyses in this study assume that this 
instrument measures one underlying construct on a unidimensional scale.  Whilst high 
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internal correlations and the factor analysis suggested evidence that this novel scale 
demonstrates internal stability, further investigation is recommended to explore construct 
validity. 
 
Differences between problematic and non-problematic chemsex 
Independent t-tests were conducted to explore the differences in shame, stress, 
mindfulness, sexual satisfaction, and self-efficacy beliefs in initiating sober sex between 
those who had self-reported positive and negative experiences of chemsex. These tests 
were all found to be statistically significant. People reporting that chemsex was having a 
negative impact on their lives described higher levels of shame t(91.12)=-5.79, p<.001; 
d=.95, stress t(180)=-6.71,p<.001; d=1.15, whereas people reporting that chemsex was 
having a positive impact on their lives described higher levels of mindfulness 
t(180)=3.86,p<.001; d=.68, sexual satisfaction t(180)=3.80,p<.001;d=.66 and self-efficacy 
beliefs t(180)=3.548, p<.001;d=.63. The effect sizes for mindfulness and sexual satisfaction, 
and self-efficacy were found to exceed the convention for a medium effect (d=.50). In 
contrast, the effect sizes for shame and stress were found to exceed the convention for a 
large effect (d=.80) (Cohen, 1988). 
Chi-square tests of independence were conducted to assess whether there were 
associations between the impact chemsex had on people’s lives and the other categorical 
chemsex engagement characteristics collected. Detailed results of the post-hoc analyses are 
reported in Appendix T. A Chi-Square test of independence revealed that, among MSM who 
engage in chemsex, the impact of chemsex (positive or negative) and whether they felt in 
control of their drugs use (Yes, no, or unsure) were significantly associated, χ2 (4, 212) = 
112.96, p < 0.0001. Post hoc comparisons (with Bonferroni correction) of impact by control 
revealed that those who thought chemsex had a negative effect on their lives also felt they 
had no control of their chemsex use (p<0.0001) or were unsure of whether they had control 
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(p<0.0001). In comparison, those who felt that chemsex positively impacted their lives also 
thought they had control over their drugs use (p<0.0001). 
A Chi-Square test of independence also revealed that the impact of chemsex 
(positive or negative) was significantly associated with whether that had ever considered 
support for their chemsex use, χ2 (4, 212) = 113.781, p < 0.0001. Post hoc comparisons (with 
Bonferroni correction) of impact by support revealed that those who felt chemsex had a 
negative effect on their lives had also considered support for their drugs use (p<0.0001). In 
comparison, those who felt chemsex positively impacted on their lives had not considered 
support for their drugs use (p<0.0001). 
A Chi-Square test of independence also revealed whether the impact of chemsex 
(positive or negative) was significantly associated with how frequently they engaged in 
chemsex in the last twelve months, χ2 (6, 211) = 17.473, p = 0.008. Post hoc comparisons 
(with Bonferroni correction) of impact by frequency of chemsex revealed that those who felt 
chemsex had a negative effect on their lives had also engaged in chemsex eleven or more 
times in the last twelve months (p<0.0001). In comparison, there was no association of 
chemsex having a positive impact on their lives with the frequency of chemsex engagement. 
A Chi-Square test of independence also revealed that there was no association of 
the impact of their drugs use (positive or negative) and whether their patterns of drugs use 
had changed over the lockdown (p=.494). 
 
Bivariate correlations 
Table 7 presents the means, standard deviations and correlations between the 
instruments used in this study. Levels of stress were significantly and negatively correlated 
with mindfulness, sexual satisfaction, and self-efficacy beliefs. Higher stress levels were 
related to lower levels of the other constructs, with correlation coefficients ranging from .29 
to .41. However, stress had a significant and positive correlation with shame, in that higher 
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levels of stress were associated with higher levels of shame. The correlation coefficient was 
.73. Shame was significantly and negatively correlated with mindfulness, sexual satisfaction, 
and self-efficacy beliefs. Higher levels of shame were related to lower levels of the other 
constructs, with correlation coefficients ranging from .36 to .47. Levels of mindfulness were 
significantly and positively correlated with sexual satisfaction (r=.38) and self-efficacy beliefs 
(r=.39). Higher levels of mindfulness were related to lower levels of the other two 
constructs. Sexual satisfaction and self-efficacy in initiating sober sex were significantly and 
positively correlated with each other (r=.55). 
 
Table 7 
Descriptive Statistics and Bivariate Correlations for the Study Variables (n=213) 
Variables M ± SD 1 2 3 4 5 
1. Stress 14.18 (9.34) -     
2. Shame 57.81 (20.95) .73*** -    
3. Mindfulness 72.10 (14.33) -.36*** -.41*** -   
4. Sexual Satisfaction 30.79 (8.69) -.41*** -.47*** .38*** -  




Hierarchical Linear Regression Analyses 
Before conducting the mediation analyses, the assumptions of normality, 
homoscedasticity, and multicollinearity were tested and met (Appendix U). Two sets of 
hierarchical linear regression analyses were conducted with shame and each of the five 
facets of mindfulness as the predictor variables. In the first set of regression analyses, sexual 
satisfaction was entered as the dependant variable, with SEISS in the second set of analyses. 
Sexual Satisfaction - Shame was entered into the first step of the model, which 
indicated it was significantly and negatively related to sexual satisfaction (b =-.47, p<.001). 
Each of the five facets of mindfulness were then entered into the second block of the model 




Hierarchical Regression Analyses for the Relationships Between Shame, the Facets of 
Mindfulness and Sexual Satisfaction 
Outcome = Sexual 
Satisfaction B SE b t P R
2 F p 
Model 1      .22 58.47 <.001 
 Shame -.19 .03 -.47 -7.65 <.001    
Model 2a      .23 31.77 <.001 
 Shame -.18 .03 -.43 -6.70 <.001    
 Nonreactivity .30 .15 .13 2.05 .04 .   
Model 2b      .29 42.34 <.001 
 Shame -.17 .03 -.41 -6.92 <.001    
 Observe .78 .17 .27 4.55 <.001    
Model 2c      .25 36.71 <.001 
 Shame -.16 .03 -.38 -5.79 <.001    
 Acting with awareness .57 .16 .22 3.45 .001    
Model 2d      .23 31.11 <.001 
 Shame -.18 .03 -.44 -7.02 <.001    
 Describe .27 .15 .11 1.78 .08    
Model 2e      .22 31.19 <.001 
 Shame -.18 .03 -.42 -6.45 <.001    
 Non-judgment .21 .12 .12 1.81 .07    
 
Results indicated that only the nonreactivity, observe and acting with awareness 
facets of mindfulness were significantly related to sexual satisfaction. However, it should be 
noted that although the facets of describe and non-judgment were not significantly related 
to sexual satisfaction, their p-values were very close to achieving significance. 
 
Self-efficacy in initiating sober sex (SEISS) - The hierarchical regression analyses were 
repeated with SEISS as the outcome variable.  Shame was entered into the first step of the 
model, which indicated it was significantly and negatively related to sexual satisfaction (b =-
.36, p<.001). Each of the five facets of mindfulness were then entered into the second block 
of the model in separate analyses (Table 9 - Models 2a to 2e). 
Results indicated that all the facets of mindfulness were significantly related to self-
efficacy in initiating sober sex. 
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Table 9 
Hierarchical Regression Analyses for the Relationships Between Shame, the Facets of 
Mindfulness and SEISS  
Outcome = SEISS B SE b t P R2 F p 
Model 1      .13 31.40 p<.001 
 Shame -.31 .06 -.36 -5.60 p<.001    
Model 2a      .17 20.80 p<.001 
 Shame -.25 .06 -.30 -4.51 p<.001    
 Nonreactivity .93 .31 .20 3.00 p=.003    
Model 2b      .21 27.63 p<.001 
 Shame -.28 .05 -.30 -4.83 p<.001    
 Observe 1.70 .37 .29 4.57 p<.001    
Model 2c      .15 18.30 p<.001 
 Shame -.25 .06 -.30 -4.30 p<.001    
 Acting with awareness .78 .36 .15 2.16 p=.032    
Model 2d      .19 24.87 p<.001 
 Shame -.25 .05 -.30 -4.65 p<.001    
 Describe 1.26 .32 .26 4.01 p<.001    
Model 2e      .16 19.50 p<.001 
 Shame -.25 .06 -.29 -4.30 p<.001    
 Non-judgment .66 .25 .18 2.60 p=.01    
 
Statistical mediation modelling analysis – Predicting Sexual Satisfaction 
Separate modelling analyses were conducted using each facet of mindfulness as 
statistical mediators between shame and sexual satisfaction (Figure 4). Those facets that did 
not significantly predict sexual satisfaction in the regression analysis were excluded (i.e., 
Describe and Non-judgment) from the mediation analysis. 
 
Figure 4 
Mediation Model – Sexual Satisfaction 
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Results from mediation modelling analysis showed that shame was significantly and 
negatively associated with nonreactivity (β = -0.06, t = -4.69, p < 0.001). This, in turn, 
predicted sexual satisfaction (β = 0.29, t = 2.05, p = 0.04). Shame was also negatively 
correlated with sexual satisfaction (β = -0.18, t = 6.70, p < 0.001). Results indicate that 
nonreactivity statistically partially mediated the association between shame and sexual 
satisfaction (indirect effect = -0.02, 95% CI -0.04, -0.00, accounting for 8.59% of the total 
effect). 
Results from mediation modelling analysis showed that shame was significantly and 
negatively associated with observing (β = -0.03, t = -2.98, p = 0.003). This, in turn, predicted 
sexual satisfaction (β = 0.78, t = 4.55, p < 0.001). Shame was also negatively correlated with 
sexual satisfaction (β = -0.17, t = -6.92, p < 0.001). Results indicate that observing statistically 
partially mediated the association between shame and sexual satisfaction (indirect effect = -
0.02, 95% CI -0.04, -0.01, accounting for 11.62% of the total effect). 
Results from mediation modelling analysis showed that shame was significantly and 
negatively associated with acting with awareness (β = -0.07, t = -6.39, p < 0.001). This, in 
turn, predicted sexual satisfaction (β = 0.56, t = 3.45, p < 0.001). Shame was also negatively 
correlated with sexual satisfaction (β = -0.16, t = -5.79, p < 0.001). Results indicate that 
acting with awareness statistically partially mediated the association between shame and 
sexual satisfaction (indirect effect = -0.04, 95% CI -0.07, -0.01, accounting for 19.40% of the 
total effect). 
 
Statistical mediation modelling analysis – Predicting Self-Efficacy in Initiating Sober Sex 
(SEISS) 
The mediation analysis was repeated with SEISS as the dependant variable, with 
separate modelling analyses conducted using each facet of mindfulness as statistical 
mediators between shame and SEISS (Figure 5). 
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Results from mediation modelling analysis showed that shame was significantly and 
negatively associated with nonreactivity (β = -0.06, t = -4.69, p < 0.001). This, in turn, 
predicted SEISS (β = 0.93, t = 3.00, p = 0.03). Shame was also negatively correlated with SEISS 
(β = -0.25, t = -4.51, p < 0.001). Results indicate that nonreactivity statistically partially 
mediated the association between shame and SEISS (indirect effect = -0.05, 95% CI -0.09, -
0.02, accounting for 16.97% of the total effect).  
Results from mediation modelling analysis showed that shame was significantly and 
negatively associated with observing (β = -0.03, t = -2.98, p = 0.003). This, in turn, predicted 
SEISS (β = 1.70, t = 4.57, p < 0.001). Shame was also negatively correlated with SEISS (β = -
0.26, t = -4.82, p < 0.001). Results indicate that observing statistically partially mediated the 
association between shame and SEISS (indirect effect = -0.05, 95% CI -0.09, -0.01, accounting 
for 15.99% of the total effect). 
 
Figure 5 
Mediation Model – Self-Efficacy Beliefs in Initiating Sober Sex 
 
Results from mediation modelling analysis showed that shame was significantly and 
negatively associated with observing (β = -0.03, t = -2.98, p = 0.003). This, in turn, predicted 
SEISS (β = 1.70, t = 4.57, p < 0.001). Shame was also negatively correlated with SEISS (β = -
0.26, t = -4.82, p < 0.001). Results indicate that observing statistically partially mediated the 
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association between shame and SEISS (indirect effect = -0.05, 95% CI -0.09, -0.01, accounting 
for 15.99% of the total effect). 
Results from mediation modelling analysis showed that shame was significantly and 
negatively associated with acting with awareness (β = -0.06, t = -6.39, p < 0.001). This, in 
turn, predicted SEISS (β = 0.77, t = 2.16, p = 0.03). Shame was also negatively correlated with 
SEISS (β = -0.25, t = -4.30, p < 0.001). Results indicate that acting with awareness statistically 
partially mediated the association between shame and SEISS (indirect effect = -0.05, 95% CI -
0.10, -0.01, accounting for 16.81% of the total effect). 
Results from mediation modelling analysis showed that shame was significantly and 
negatively associated with describing (β = -0.04, t = -3.64, p < 0.001). This, in turn, predicted 
SEISS (β = 1.26, t = 4.01, p < 0.001). Shame was also negatively correlated with SEISS (β = -
0.25, t = -4.65, p < 0.001). Results indicate that describing statistically partially mediated the 
association between shame and SEISS (indirect effect = -0.05, 95% CI -0.10, -0.02, accounting 
for 17.33% of the total effect). 
Results from mediation modelling analysis showed that shame was significantly and 
negatively associated with non-judgment (β = -0.09, t = -5.86, p < 0.001). This, in turn, 
predicted SEISS (β = 0.66, t = 2.60, p = 0.01). Shame was also negatively correlated with SEISS 
(β = -0.25, t = -4.30 p < 0.001). Results indicate that non-judgment statistically partially 
mediated the association between shame and SEISS (indirect effect = -0.06, 95% CI -0.11, -




The World Health Organisation (WHO) defines sexual health as “a state of physical, 
emotional, mental and social well-being in relation to sexuality”, not just the absence of 
disease (WHO, 2006a). To this end, this study aimed to increase the evidence base about 
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well-being amongst MSM who engage in chemsex. The present study contributes to the 
previous literature in two important ways, extending the evidence base to MSM who engage 
in chemsex whilst understanding those whose chemsex engagement positively or negatively 
impact their lives. This gives some insight into the relationships between theorised factors 
influencing the initiation of chemsex use and the barriers to re-engaging in sober sex. 
Significant gaps remain in understanding the role of shame and mindfulness in behaviours 
associated with chemsex use. Still, this study confirms several trends that are beginning to 
emerge in general substance use literature. 
Research suggests that most MSM who engage in chemsex report that it positively 
impacts their lives, with a minority experiencing problematic chemsex and struggling to re-
engage in sober sex (Milhet et al., 2019; Schlag, 2020). Those who experience a problematic 
relationship with chemsex and try to seek help often struggle to find adequately resourced 
support (Bourne et al., 2014). Supporting previous research, most participants of this study 
(64%) reported that chemsex was having a positive impact on their lives. MSM who reported 
that chemsex positively impacted their lives were more likely to have higher levels of 
mindfulness, sexual satisfaction, and self-efficacy beliefs in initiating sober sex. Those who 
reported that chemsex was having a negative impact on their lives were more likely to have 
higher levels of stress, to have considered support and felt less in control of their substance 
usage and were more likely to have engaged in chemsex more than eleven times in the last 
twelve months. This supports qualitative evidence that suggests one in four MSM wish to 
seek support for chemsex-related issues including self-control, and physical and mental 
health difficulties (Evers, 2020). However, due to this study’s design temporal causality 
cannot be assumed. For example, the study cannot determine whether those reporting 
higher levels of shame and stress are more likely to engage in chemsex as a coping 
mechanism for these aversive affective states, or whether problematic chemsex causes 
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higher levels of shame and stress in an individual. Whilst it is possible that both these 
mechanisms operate together maintaining a person’s difficulties, further research would be 
required to disentangle them. 
This study found strong, negative relationships between shame and sexual 
satisfaction and self-efficacy for initiating sober sex. This supports previous evidence that 
individuals with higher levels of shame experience lower levels of sexual satisfaction (Reid et 
al., 2009) and lower sexual self-efficacy levels (Baldwin et al., 2006). The strongest 
relationship was shown to be between shame and stress, with higher levels of shame 
associated with higher stress levels. This study’s findings are supported by research over the 
last two decades that consistently suggests shame has a detrimental effect on mental health 
symptomology (Tangney & Dearing, 2002). However, due to the relative strength of this 
relationship in this study, an item-level comparison was made between the ISS and the 
DASS-21 subscales to investigate if there was any overlap. Whilst there were no items 
directly equivalent to each other, items such as “I found it hard to wind down” from the 
DASS-21 and “I replay painful events over and over in my mind until I am overwhelmed” 
from the ISS may tap into similar experiences. However, the National Survey on Drug Use 
and Health (NSDUH) recently compared heterosexual and homosexual substance users and 
found that MSM experienced greater levels of stress and had a higher risk of developing 
mental health difficulties (Medley et al., 2015). As such, whilst there is potential for item 
overlap between the ISS and DASS-21 to explain some of the strength of the relationship 
between shame and stress, the intersectionality of shame relating to substance use and 
being a sexual minority may also reinforce this relationship.  
This study’s results also replicate the evidence from heterosexual populations 
whereby a strong positive relationship exists between mindfulness with sexual satisfaction 
(Khaddouma et al., 2015)and self-efficacy (Luberto et al., 2014). Similarly, this study found a 
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strong and negative relationship between mindfulness and levels of distress, confirming 
previous research findings (Khoury et al., 2015; Schumer et al., 2018). 
There is a growing evidence base for the effectiveness of mindfulness-based 
interventions for both substance use and sexual difficulties (Brem et al., 2017). However, the 
relationships underpinning these interventions have not been explicitly investigated within 
the current population. It is important to research potential mechanisms of change for those 
who require support for chemsex use. The exploration of a possible statistical mediation 
effect of mindfulness between shame and sexual satisfaction and shame and self-efficacy for 
initiating sober sex was partially confirmed. The results suggest differences in the statistical 
mediation effects of individual facets of mindfulness on their relationship to sexual 
satisfaction compared to their relationship to self-efficacy beliefs in initiating sober sex.   
Three of the five mindfulness facets had significant statistical mediating relationships 
between shame and sexual satisfaction, these being nonreactivity, observe and acting with 
awareness. These results support previous research that suggests that dispositional 
mindfulness is positively associated with sexual satisfaction through increased attention 
regulation, body awareness and emotional regulation (Khaddouma et al., 2015). Although a 
causal relationship cannot be inferred, these results make sense in the context that higher 
levels of shame have the effect of turning people away from intimate relationships (Black et 
al., 2013). However, it would be important to explore whether developing interventions to 
increase mindfulness skills is enough from a clinical perspective. An important research 
question to explore is whether one would need to reduce shame first to allow mindfulness 
skills to improve. 
Two of the facets within this population did not statistically mediate the relationship 
between shame and sexual satisfaction (i.e., describe and non-judgment), although their p-
values were very close to achieving significance. These results contradict previous research 
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that suggests individuals who can more effectively articulate affective experiences (i.e., the 
describing facet) may have a set of communication skills that regulate sexual satisfaction 
(Brem et al., 2019). Similarly, prior research supports the hypothesis that greater judgment 
towards internal and external experiences (i.e. the judgment facet) was highly predictive of 
sexual difficulties in men with high levels of shame (Reid et al., 2009). Furthermore, 
researchers have found that some individuals temporarily alter or reduce thoughts and 
experiences such as shame to reduce painful experiences (e.g., depression and anxiety) 
using maladaptive coping mechanisms such as substance use (Deneke et al., 2015). 
However, the FFMQ instrument measures levels of mindfulness as applied to general 
situations. For example, items such as “I tell myself that I shouldn’t be feeling the way I’m 
feeling” or “I disapprove of myself when I have illogical ideas”. Some research suggests that 
some aspects of the FFMQ are heavily dependent on the context under investigation (Adam 
et al., 2015). In their paper on developing a sexual FFMQ (FFMQ-S; Adam et al., 2015), the 
authors demonstrated that adapting the scale to ask specific questions about mindfulness in 
sexual situations had stronger correlations with a person’s level of distress. For example, 
items were rescripted to “I don’t criticise myself when I have sexual fantasies that I consider 
to be taboo” to reflect the evaluation of one’s experiences relating to sex. As it has been 
hypothesised that some MSM are highly critical about their sexual performance and 
experiences (Carvalheira & Costa, 2015), this may suggest the general FFMQ may not be 
sensitive enough to discern the specific difficulties some have concerning sexual and 
intimacy difficulties.  If the describing and non-judgment questions were specific about 
sexual experiences, a significant association with levels of sexual satisfaction might have 
been achieved. 
Finally, as measured by the FFMQ, all five facets of mindfulness had a significant 
statistical mediating relationship between shame and self-efficacy in initiating sober sex. 
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This is an important finding as beliefs in one’s ability to engage in an activity (i.e., engaging in 
sex without relapsing) have been shown to predict behaviour (Bandura, 1986) but also 
improvements in self-efficacy influence one’s sexual well-being (Milhet et al., 2019) 
Although these findings can determine neither the directionality nor causality of the 
relationships, they may indicate areas to research potential interventions for problematic 
chemsex. Interventions focused on developing mindfulness may mediate the development 
of increased self-efficacy in engaging in sober sex, which may establish an improved sense of 
sexual well-being (Milhet et al., 2019). As self-efficacy beliefs are domain-specific, and 
beliefs in initiating sober sex have not been previously studied, there is no direct comparison 
against the evidence base. However, this study’s results support previous research that 
suggests trait mindfulness has a positive relationship with self-efficacy in various domains 
(Chang et al., 2004; Cusens et al., 2010; Luberto et al., 2014).  
 
Chemsex during the Coronavirus pandemic 
The inclusion of additional questions during the piloting phase enabled this study to 
explore potential changes in chemsex engagement during the national lockdown. To reduce 
Coronavirus transmission, the social distancing measures reduced an individual’s access to 
social support, increasing a sense of isolation in many MSM (Brennan et al., 2020). Despite 
restrictive governmental measures, many MSM reported continuing engaging in chemsex 
during social distancing (de Sousa et al., 2020). The findings of this study supported this with 
59% of respondents disclosing that their chemsex engagement remained the same over 
lockdown or had increased. Chemsex parties are contexts in which participants would have a 
particularly high chance of infection due to meeting multiple people, for long periods of 
time,  with different histories of exposure to the virus (de Sousa et al., 2020). Despite 
knowing the risks of acquiring the Coronavirus virus, this was not enough to prevent MSM 
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from meeting. Findings from this study found no association between changes in chemsex 
use over lockdown and whether chemsex was having a positive or negative effect on their 
lives. This supports previous research that suggested that MSM who engage in regular drug 
use, regardless whether it was problematic or not, have lower risk perceptions (Evers et al., 
2020). Examples of lower risk perceptions include a lack of adherence to preventive 
measures associated with sexually transmitted and other infections (Lea et al., 2019). This 
study suggests that the risk perceptions of individuals who engage in chemsex use, are not 
influenced by whether their engagement is problematic or not. 
The addition of “video platform” to the list of contexts in which chemsex was 
engaged was in response to the EBEs, suggesting that this medium was becoming more 
prevalent, especially in response to the national lockdown. A minority of respondents in this 
survey, 36%, reported having engaged in chemsex via video platforms. “Digital chemsex” is a 
relatively new phenomenon comprising of group play activities from exchanging information 
about other individuals and encounters, filming sex, watching porn collectively whilst under 
the influence of drugs (Møller, 2020). The increase in the use of video platforms during 
lockdown has facilitated digital chemsex, where meetings are not easily publicly available or 
visible and are generally unmoderated (Platteau et al., 2020). As such, this provides a much 
more private experience and is thought to facilitate the use of these services for non-
normative and socially marginalised sex and drug practices (Møller, 2020). 
 
Limitations 
This study is subject to some fundamental limitations. The study employed a 
retrospective, cross-sectional design, and as such, the temporal relationship between 
shame, the facets of mindfulness, and sexual satisfaction or self-efficacy cannot be 
confirmed. Research using randomised control trials and longitudinal designs may more 
clearly determine whether mindfulness facets mediate these relationships.  
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The cross-sectional design also limits any ability to draw causal conclusions from 
results. Research suggests that cross-sectional approaches to mediation typically generate 
biased results compared to analyses derived from longitudinal data (Maxwell & Cole, 2007). 
However, the authors stated that there might be notable exclusions in a more recent paper. 
For example, where the independent variable level is relatively fixed over time (Maxwell et 
al., 2011). Within this study, the independent variable is shame, which is relatively high in 
MSM who engage in chemsex compared to the general population (Pollard et al., 2018). It 
has also been shown that MSM with medium to high levels of internalised homophobia and 
shame demonstrate very little change over time, with the levels remaining remarkably 
stable (Puckett et al., 2018). Whilst causation cannot be inferred, the presence of a relatively 
stable independent variable reduces some of the bias prone to using cross-sectional data for 
mediation analyses.    
The study initially planned to recruit from three potential pathways: NHS sexual 
health services, LGBT support organisations and geospatial dating apps. Due to the national 
lockdown, whereby services began operating remotely and were unable to engage with the 
research project, most participants were sourced from the dating apps. This potentially 
introduced a selection bias, as those accessing support services are more likely to be 
experiencing a negative impact of chemsex engagement on their life. Most participants for 
this study (64%) reported that chemsex was positively impacting their lives. Although this 
reflects research that suggests that most people who engage in chemsex report that it has a 
positive impact on their lives (Schlag, 2020), future research may want to broaden 
recruitment to services supporting people with problematic chemsex use. 
The use of self-report measures also potentially introduces social desirability biases, 
even though the key constructs were measured using instruments with good psychometric 
properties. Their brief format allows for efficient administration.  However, future studies 
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can ameliorate biases by employing objective measures (e.g., urine tests to measure drug 
use) and mixed-method approaches.  
The decision to use the FFMQ limits the interpretation of the results to the five 
facets of mindfulness as defined by this measure. Using alternate measures with different 
subscales, such as the Philadelphia Mindfulness Scale (Cardaciotto et al., 2008), may 
demonstrate other relationships. Future research should include a broader range of 
mindfulness measures in addition to the related constructs.  
Self-efficacy beliefs are highly domain-specific (Bandura, 1986). As there is no 
instrument currently validated to measure self-efficacy beliefs in engaging in sober sex, a 
novel measure was developed specifically for this study in collaboration with experts by 
experience and a specialist clinician. The psychometric properties of this instrument indicate 
a strong internal validity, measuring a single construct. However, it is recognised that if the 
new scale is to be used in other research projects, a formal development of this scale is 
essential. This is particularly important due to this study’s cross-sectional design limiting the 
ability to estimate the temporal stability of the model’s parameters (Morgado et al., 2018). 
Further ratification will be required to evaluate this novel measure’s construct validity and 
reliability. To increase this measure’s generalisability would also require a non-convenience 
recruitment strategy, drawing from a heterogeneous sample population.  
This research did not investigate the effect of comorbid symptoms, such as  
depression and anxiety, that may moderate the relationship between mindfulness and 
sexual satisfaction and self-efficacy (Brem et al., 2017). This is particularly important as 
negative affect is one of the main factors hypothesised to predict substance use relapse 
(Brem et al., 2019)and may be an important consideration in relapse prevention (Levin et al., 
2014). Given that there is a hypothesised relationship between affect and relapse, further 
research may focus on whether affect moderates the influence of mindfulness found in this 
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study. This study also did not investigate other factors known to be influential in substance 
use, such as emotional regulation (Gratz & Roemer, 2003), impulsivity (Murphy & MacKillop, 
2012) and distress tolerance (Leyro et al., 2010). Extending this research to include these 
other variables may help understand the potential mechanisms for change in chemsex use 
and its impact on well-being. 
To explore the broadest possible experience of chemsex use, this study included 
participants with non-problematic versus problematic engagement with substance use. 
However, neither the correlational nor mediation analyses explored differences between 
these two groups of participants. While this introduces a known heterogeneity into the 
sample, previous research empirically supported this approach, which has found minimal 
value in distinguishing between those who use substances from those with substance 
dependence (Hasin, 2012). However, it may be fruitful for future research to examine any 
phenomenological differences between those whose chemsex experience positively 
impacted those whose experience is negative.  This may help target interventions based 
explicitly upon those who require different types of support for their substance use. These 
may include harm reduction strategies and relapse prevention.  
 
Conclusion 
This research investigated the experiences of MSM who engage with chemsex. It 
approached this subculture from a destigmatising position, acknowledging the negative 
consequences of drug use without overlooking the positive value that chemsex can have in 
the lives of those who engage in it. 
The findings add to the evidence base that supports the investigation of mindfulness 
interventions for this population.  The study also supports testing a multi-faceted approach 
targeting the other psychological constructs identified in this study as potential areas to 
develop. These include shame, self-efficacy beliefs, and affect. Most people who engage in 
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chemsex do so non-problematically, with only a minority reporting it negatively impacts 
their lives and wish to access support. However, the findings suggest that users might 
benefit from harm reduction approaches, even in the absence of problematic drug use. 
Despite its limitations, this present study supports the growing evidence that interventions 
based upon specific facets of mindfulness may support those who engage in substance 
misuse in sexual contexts (Levin et al., 2014). However, further research is needed to 
evaluate the facets of mindfulness to identify those involved in maintaining difficulties 



















V. Integration, impact, and dissemination plan  
 
Integration 
The two components of this project are a systematic review, including a meta-
analysis and an empirical project. Both investigated different but closely related questions 
about mindfulness in men who engage in substance use. Problematic illicit drug use is a 
complex and often relapsing chronic condition, requiring a multi-faceted and coordinated 
care and intervention approach. However, whilst the evidence base for the usefulness of 
mindfulness-based interventions (MBIs) in treating substance user difficulties is growing, 
there is limited research about good practice in drug treatment specifically for male drug 
users (Williams et al., 2010). Men are an important group to research as, historically, they 
have relatively higher prevalence rates of illicit substance misuse than women and are more 
reluctant to seek support (Elmquist et al., 2017).   
The systematic review and meta-analysis focused on randomised-controlled trials 
(RCTs) evaluating the effectiveness of mindfulness-based interventions (MBIs) on substance 
use outcomes in men. In the past two decades, research into mindfulness-based 
interventions (MBIs) has yielded promising results for substance misuse treatment (Chiesa & 
Serretti, 2014; W. Li et al., 2017b), with a large proportion of the studies focusing on alcohol 
(Byrne et al., 2019) and tobacco (Maglione et al., 2017) addiction. At the time of writing up, 
no systematic review could be found that focused on the effectiveness of MBIs on men 
whose primary treatment was for illicit drugs and not for alcohol or tobacco. It was decided 
that it was important to evaluate this specific subset of substance use, as research suggests 
that the predictors of substance use and relapse may vary depending on drug type (Enkema 
et al., 2020). 
The primary outcomes of the interventions selected for the systematic review were 
frequency of substance use/abstinence and substance cravings. Secondary outcomes varied 
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from levels of affect/distress to quality of life. The systematic review asked two main 
questions. First, does the evidence support the hypothesis that MBIs generate positive 
outcomes in substance-using male populations? Secondly, what is the overall effect size of 
the impact of MBIs on substance use cravings in men? In answer to the first question, the 
systematic review found that the included studies consistently found MBIs to be associated 
with positive health outcomes across various interventions used, the contexts within which 
the studies took place, and the substances used. The second question was partially 
answered by the meta-analysis, which found that the included studies demonstrated effects 
sizes from small to large—still, all indicating reductions in substance craving after 
posttreatment.  
Overall, the systematic review supported the growing evidence base for positive 
outcomes of MBIs for men being treated for substance misuse. The confirmation of the 
effectiveness of mindfulness in the treatment of male-only, illicit substance-using 
populations supported the conceptual basis of the empirical study, which focused on a 
subset of this population.   
The two components of this thesis had different aims; they are rooted within the 
same context, and both investigate mindfulness in men who engage in problematic illicit 
drug use. Whilst the purpose of the systematic review to evaluate RCTs and estimate the 
effectiveness of mindfulness in treating illegal substance use, the empirical study employed 
a cross-sectional design to explore the associations between psychological constructs 
theorised to contribute towards maintaining substance use alongside sex.  
The empirical study employed a cross-sectional design recruiting a sample of 
participants who fall within the inclusion criteria of the systematic review, that is substance-
using men. However, the study focused on an area with a much more limited research base: 
men who have sex with men (MSM) who engage in sexualised drug use. More specifically, 
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chemsex involving three specific drugs (i.e., methamphetamine, g-hydroxybutyrate and 
mephedrone) used to enhance the sexual experience. An increase in chemsex engagement 
has been reported in the last ten years (Platteau et al., 2020), along with detrimental 
physical and mental health outcomes in some users. Recent research suggests that 
substance use and relapse predictors may vary depending on drug type (Enkema et al., 
2020). As there is limited evidence-based research for drugs commonly implicated in 
chemsex, the empirical study aimed to explore possible factors theorised to be involved in 
the maintenance of chemsex behaviours, with the hope of suggesting directions for targeted 
theory-derived interventions.  
However, whilst the evidence base for the usefulness of MBIs in treating substance 
user difficulties is growing, there is a lack of evidence about good practice in drug treatment 
for MSM service users (Williams et al., 2010). Without specific theory-driven interventions 
for chemsex, many services support those seeking treatment by employing traditional 
substance misuse interventions to jointly address substance and sexual risk (Moncrief, 
2014). As the landscape of substance use changes, with the emergence of novel drugs 
continually appearing on the market and new polysubstance combinations, the 
development of targeted and relevant services is ongoing (van Amsterdam et al., 2010). 
Supported by the evidence from the systematic review, the empirical study aimed to explore 
possible factors theorised to be implicated in the maintenance of chemsex behaviours, with 
the hope of suggesting directions for targeted theory-derived interventions. 
Most of the studies included in the systematic review had outcomes that showed 
reductions in anxiety and depression posttreatment (Carrico et al., 2019; Chen et al., 2019; 
Lee et al., 2016; Lyons et al., 2019) although this was not typically a primary focus of 
therapy. The relationship between stress and substance use is well-established, whereby 
increased levels of anxiety and depression are associated with an increased risk of substance 
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misuse (Bowen et al., 2014). MBIs may reduce addiction behaviours through developing 
alternate stress management strategies, reducing the reliance on substances for relief from 
distress symptomology.  
The purpose of the empirical study was to explore the relationships between 
psychological constructs thoughts to influence MSM’s experience of chemsex, namely 
shame, distress, dispositional mindfulness, sexual satisfaction, and self-efficacy beliefs in 
initiating sober sex (i.e., sex without needing drugs or alcohol).  
The systematic review findings suggest that mindfulness-based interventions 
generate positive outcomes for men with substance use difficulties, regardless of the 
mindfulness intervention employed. In particular, the included studies demonstrated 
reductions in substance cravings and relapse rates posttreatment. These results were in line 
with existing research for MBIs as substance user treatments. Based upon the existing 
evidence base, it was broadly anticipated that the results from the empirical study would 
indicate that there would be a relationship between mindfulness and the constructs known 
to be associated with chemsex use. The constructs investigated were shame, stress, sexual 
satisfaction.  In addition, a new instrument designed to measure self-efficacy beliefs in 
initiating sober sex, which may add to the field. In this way, the empirical study corroborated 
the findings from the systematic review. Shame and distress were found to be negatively 
associated with mindfulness, sexual satisfaction, and self-efficacy. In turn, mindfulness was 
positively related to sexual satisfaction and self-efficacy. Statistical mediation analyses 
confirmed that the mindfulness facets of observing, acting with awareness and nonreactivity 
have an association with the relationship between shame and sexual satisfaction. The results 
suggest that all five facets of mindfulness (i.e., observing, describing, acting with awareness, 
non-judgment and nonreactivity) have an association with the relationship between shame 
and self-efficacy. 
 94 
Mindfulness is becoming more widely accepted as an effective treatment for 
substance use (Enkema et al., 2020)and sexual difficulties (Brotto et al., 2016; Leavitt et al., 
2019).  The systematic suggests that MBIs are appropriate for reducing substance cravings 
relapse in male’s engaging in problematic illicit drugs use and is an acceptable mode of 
intervention to this population. The empirical study, whilst linked to the systematic review 
through its investigation of mindfulness in men, focusing the current evidence base by 
investigating MSM within the context of chemsex. This study’s findings theoretically support 
the development and possible implementation of MBIs in this group. As this study has 
confirmed that shame is associated with lower self-efficacy beliefs in initiating sober sex and 
higher levels of distress, it may be important to consider these when developing MBIs for 
those who engage in chemsex. Further research would be needed to investigate the specific 
facets of mindfulness that would be most influential in developing mindfulness-based 
relapse prevention treatments.  
 
Reflections 
Most of this project has taken placement during national lockdowns during the 
Coronavirus pandemic. Soon after the empirical project proposal was accepted, households 
and businesses were advised to stay home to control the infection rates and reduce the 
burden on NHS services. Conducting research within the context of the lockdown in a period 
of social isolation made me consider the importance of working creatively and flexibly. 
As it became clear that the infection trajectory of the virus was difficult to predict, I 
began to reflect on the impact that this would have on this study. I felt that this would affect 
several key areas. Most significantly, this would have a direct effect on the recruitment 
strategy. The original project proposal hoped to recruit service users who accessed the three 
NHS sexual Health services who had agreed to be recruitment sites and nationwide LGBT 
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support organisations. However, after the lockdown, most services began to operate 
remotely, with clinicians working from home and many service users accessing service via 
digital platforms. Due to the increased demands placed upon clinician and reduced access to 
service users, all three NHS sexual health services and the majority of LGBT support 
organisations reported that they did not have the capacity to support the recruitment 
process.   
As the NHS services and third sector support services could not support the study, 
my attention was focused on direct recruitment on geospatial dating apps. To broaden the 
study’s reach and increase its generalisability, I also worked on advertising it via the social 
media accounts of several national LGBT support organisations. Profiles on geospatial dating 
apps and social media advertisement were embedded with the same information and links 
to the study website (Appendix I). Research has shown that recruiting hard-to-reach 
populations through social media (Evers et al., 2020) and geospatial dating apps (Iott et al., 
2018) can be as effective with similar survey completion rates compared to traditional face-
to-face approaches. The dating apps were deemed to be a particularly appropriate platform 
as some are known to be one of the primary vectors in which chemsex drugs are procured 
and “chill out parties” are organised (Ahmed et al., 2016). Apps allow MSM to easily and 
anonymously align their specific desires and practices with those with similar interests (de 
Sousa et al., 2020). The advertisement on the dating apps was non-person centred, making it 
clear this was a study-specific profile. The title of the profile was “Researcher”, and no 
sections regarding personal characteristics were completed. None of the participants were 
contacted directly, and any questions were answered professionally. The language of the 
study information linked to the profile (Appendix G) was intentionally destigmatising, 
focusing on the need to understand chemsex, which is of interest to this group.   
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However, advertising via the apps was very time-consuming, and I had 
underestimated the amount of time this would take. To reach as many potential participants 
as possible, I spent a substantial amount of time travelling to various London areas to access 
users from different locations. Although Covid guidelines and precautions were followed, 
this placed an additional burden during a time of uncertainty and increased anxiety. 
As the purpose of the lockdown was to minimise face-to-face contact to reduce viral 
transmission.  I presumed that the lockdown would impact people’s engagement in 
chemsex. I initially felt that the lockdown would reduce users’ abilities to procure chemsex 
drugs and that people would be less likely to host ‘chill out parties’, where most participants 
engaged in chemsex. With a reduction in chemsex engagement, there was the potential that 
there would be less interest in the study. However, the EBEs were confident that many users 
continue to engage in chemsex, despite the lockdown, and that this would probably lead to 
more people using video platforms to host chemsex parties. They also believed that in 
response to the additional stressors at the time and increased opportunity some chemsex 
engagement would likely increase during the lockdown. Many individuals were placed on 
furlough during this time. They continued to be paid a salary, but had reduced day-to-day 
work responsibilities, and increased free time. To monitor this, two additional questions 
were added to the survey. The first was to include video platform as an additional context 
over which chemsex took place, and the second was a question asking whether they had 
changed their use pattern during the pandemic. Input from the EBE enabled these important 
additions, which gave an opportunity to understand how this population would respond to 
the lockdown. 
Interestingly, research into chemsex engagement during the lockdown found some 
of the chemsex behaviours did change during the lockdown as it was reported that chemsex 
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parties were adapting to video platforms and taking place online (Møller, 2020). This study 
supports these findings. 
Conducting the quality assessment of the systematic review allowed me to look at 
the design of the empirical study more objectively, albeit in retrospect. In turn, this enabled 
me to reflect on the study’s limitations in more details and articulate these more fully in the 
discussion chapter. I became more acutely aware of the need for transparency in the study 
design for researchers to evaluate and replicate the study thoroughly. I also became more 
acutely aware of the limitations of this study and how this may introduce potential biases 
(e.g., social desirability bias in self-report measures). Applying a methodological assessment 
approach to any future research should hopefully inform the study design, raising awareness 
of biases and potentially ameliorating them.  
 
Impact 
This study supports previous research that suggest most individuals who engage in 
chemsex do so non-problematically, with it having a positive impact on their lives. Those 
who reported non-problematic usage felt in control of their drugs use and had not 
considered accessing support. These individuals reported lower levels of shame and stress, 
and higher levels of mindfulness, sexual satisfaction, and self-efficacy to initiate sober sex. 
These individuals as less likely to be known to drugs services, although they may access 
sexual health services if exposed to sexually transmitted diseases. Most respondents in this 
study appear to experience higher levels of sexual well-being, that is higher levels of sexual 
satisfaction and self-efficacy beliefs. 
In comparison, a minority of respondents reported that chemsex was having a 
negative impact on their lives, felt they were not in control of their drugs use, was 
associated with higher frequency drug use, but also associated with considering accessing 
support for their drugs use. However, most substance users who want support fail to access 
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treatment and relapse prevention interventions (United Nations Office on Drugs and Crime 
[UNODC], 2019). Therefore, it is essential to continually research and increase the evidence 
base of effective and acceptable interventions to treat drug use disorders. 
It is hoped that the impact of this project contributes towards both the academic 
understanding and clinical applications of the constructs investigated. Specifically, adding to 
the growing evidence base for the effectiveness, and appropriateness, of mindfulness-based 
interventions (MBIs) for men with substance use difficulties and suggesting potential 
directions in which MBIs could be developed for men engaging in problematic chemsex. The 
direct beneficiaries of developing targeted and cost-effective support for men who engage 
in chemsex include clinicians within sexual health and substance use services, third sector 
LGBT support organisations, and the service users. Specific support services for people 
engaging in chemsex are uncommon (Platteau et al., 2020), with few of these services 
providing empirically supported intervention programs (Graf et al., 2018). It is hoped that 
increasing awareness of and building confidence in working with chemsex will better equip 
clinicians to improve service provision and hopefully increase treatment effectiveness. There 
is also the potential for indirect benefits, such as reducing barriers to individuals accessing 
services through increased awareness by clinicians (Miller-Lloyd et al., 2020). In summary, 
the results of both the systematic review and empirical study have implications on the 
understanding and clinical training of health professionals and broader commissioning of 
service provision for chemsex support. 
From a theoretical perspective, the current project reinforced our understanding of 
the effectiveness of MBIs on men with substance use difficulties. Previous research has 
identified the hypothetical mechanisms by which mindfulness is thought to modify the main 
features of substance use (e.g., triggers, craving and relapse). This study provides additional 
empirical support for existing research that indicates that MBIs yield promising results for 
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substance misuse treatment (Chiesa & Serretti, 2014; Li et al., 2017). These results support 
with theories that suggest increased mindfulness may disrupt the cycle of affection, 
cognitive and physiological mechanisms that maintain substance use and sexual difficulties 
(Brem et al., 2017; Katz & Toner, 2013).  
Self-efficacy is not only an important predictor in many cognitive behaviour models 
of behaviour change, such as social learning theory (Møller, 2020), but is also positively 
related to a person’s well-being (Mastro & Zimmer-Gembeck, 2015). However, self-efficacy 
is behaviour specific, with a person’s beliefs in their ability varying depending on the 
behaviour being actioned. It was appropriate that a novel instrument be developed for this 
project, the Self-Efficacy in Initiating Sober Sex. Similar scales have been developed for prior 
research into substance use relapse. For example, the Alcohol Abstinence Self-efficacy Scale 
(AASE; DiClemente et al., 2015) or the Self-efficacy and Temptation scale for drug users 
(Hiller et al., 2000). This instrument was developed in collaboration with the EBEs. It was 
refined over time to focus on the initial barriers in engaging in sober sex. These include the 
likelihood of feeling sexually attractive or their confidence in making advances to a sexual 
partner. The findings of this study included an assessment of the internal consistency of this 
questionnaire. Future work needs to replicate these findings, alongside evaluating its 
external validity against existing measures and related constructs. There is the potential of 
using this instrument as a part of the treatment process. Work would involve examining 
changes in the scores of the SEISS and relating these to therapeutic events, drug use and 
relapse. 
Shame, stress, sexual satisfaction, self-efficacy, and mindfulness have all been 
shown to have significant relationships with each other within this population. The results 
suggest that all these factors may be important in guiding the approach for a therapeutic 
intervention and should be considered when formulating an individual’s difficulties. This is 
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particularly important in MSM who engage in chemsex, as the high levels of shame found 
can act as a barrier to successful therapy. Research has found that shame is a significant risk 
factor for developing a poorer therapeutic relationship (Black et al., 2013). Most notably, 
individuals with high shame often employ a withdrawal style (i.e., shutting down) and are 
less likely to develop an effective therapeutic alliance. There is also potential practical utility 
in the findings that those who report that chemsex is having a negative impact on their lives 
also report higher levels of shame and stress. Whilst this study’s results cannot infer any 
temporal relationship between shame and stress and problematic chemsex use, regular 
assessment of both constructs, and frequency of chemsex use, may indicate help identify 
individuals at risk of developing problematic drugs use. Appropriate clinical pathways can be 
developed based on an individual’s changing needs, and position on the chemsex journey.  
Given the multi-faceted nature of MSM who engage in chemsex, the findings from 
this study suggest that developing mindfulness may be a very important skill to build. 
However, mindfulness by itself may not be enough to shift the other constructs in some 
people, and a multi-modality approach may be necessary depending on an individual’s 
difficulties. For example, a CBT intervention might specifically be looking at building upon 
self-efficacy beliefs by developing psychosexual skills building (e.g., managing difficulties 
during sexual encounters or communications). A CFT intervention might be looking at how 
to find ways to understand and manage shame. Group work can also function to de-shame 
and allow MSM to enhance relational skills with one another in a non-sexual context (Hoff et 
al., 2020). Further work is required to investigate whether other interventions could focus 
on the other constructs.  
The empirical study has already directly impacted the experts' involvement by 
experience (EBEs). The EBEs have been involved in all stages of the research and have 
shaped its design and continue to guide its direction. In particular, the EBEs were 
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instrumental in identifying self-efficacy as an important construct to measure, but also in 
developing the novel instrument. Creating the measure was an iterative process, which 
increased the amount of time it took to complete. However, it was felt to be important to 
get right. The EBEs were able to narrow down the measure’s focus from identifying vague 
beliefs around barriers to sober sex to specific behaviours associated with initiating sober 
sex. 
There is a lack of research about good practice in substance misuse treatment for 
MSM service users. Only a few studies measure outcomes or evaluate service use by sexual 
orientation (Williams et al., 2010). The EBEs were able to confirm this anecdotally when 
recalling their own negative experiences when trying to access appropriate health care or 
finding clinicians unaware of the complexities of chemsex. The EBEs both stated that more 
targeted service development was required and felt this study was important to support 




The findings of this research were presented to a cohort of peers, academic staff 
and collaborators at Royal Holloway, University of London. The presentation was co-created 
with the EBEs. Feedback from the presentation was elicited from the audience and 
incorporated in the write-up as appropriate. The next stage will be creating a summary of 
the findings for the EBEs and LGBT support organisations. Third sector organisations will be 
encouraged to share the results with their networks. Also, it will be shared with the NHS 
sexual health services who agreed to participate but were unable to due to the pandemic. 
The study summary will be created in collaboration with the EBEs and will include an 
overview of its results and potential clinical utility. Participants were invited to request a 
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summary of the results once the project was completed. However, this offer was not taken 
up by any of the participants. The EBEs felt that as this was an anonymised survey, some felt 
some participants would not feel comfortable supplying personally identifiable information 
(i.e., their email address) due to the nature of the study. 
It is also planned that the systematic review and empirical study will be submitted 
for publication in relevant journals to disseminate the findings to academic audiences 
further. The systematic review is a helpful synthesis of research explicitly focused on the 
effectiveness of MBIs in males who engage in problematic illicit drug use. It supports the 
usefulness and appropriateness of this treatment for men. Research into chemsex is 
relevant across physical and mental health domains and those working with MSM sexual 
minority groups. It is hoped that this research supports the usefulness of mindfulness-based 
approaches for chemsex and indicates a direction for further research in developing 
targeted interventions. The journals which would be most appropriate include the 
Psychology of Addictive Behaviors, Mindfulness and AIDS and Behaviour. Also, it is hoped to 
present the findings at relevant conferences such as the British Psychology Society’s HIV and 
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Systematic Review Protocol 
Research question 
State a specific research 
question for the review 
 
What is the evidence that mindfulness-based 
interventions improve the substance misuse behaviours 
in men? A systematic literature review 
Link with empirical study 
Clarify and justify link with 
empirical study  
The empirical study will focus on whether mindfulness is 
associated with the self-efficacy beliefs of MSM who 
engage in chemsex can initiate sober sex 
Eligibility criteria 
State the characteristics of 
eligible studies (e.g., designs; 
participant characteristics; 
setting; dates; language; 
methodology) 
Methodology/Designs 
Inclusion Criteria – Published quantitative studies will 
only be included (RCTs). Exclusion Criteria – Non-RCT 
studies, qualitative studies, quasi-experimental studies, 
case reports 
Language 
Inclusion Criteria - Only studies published in English will 
be included. 
Participant characteristics 
Inclusion Criteria – Adults (18+) diagnosed with a 
substance use disorder 
Gender 
Inclusion Criteria - Only studies with male participants 
will be included 
Exclusion criteria – Studies that are mixed-gendered or 
female only. 
Dates 
Inclusion Criteria - There will be no date restriction. 
Search terms 






The following search terms will be used:  
 
• Concept 1 – Mindfulness 
“mindfulness” OR “mindfulness intervention” OR 
“mindfulness meditation” OR ”mindfulness treatment” 
OR 
“mindfulness-based relapse prevention” OR “MBRP” 
 
• Concept 2 – Substance Misuse 
"substance misuse" OR "substance use" OR "drug abuse" 
OR “*use disorder” 
 
Number of articles initially 
located using search terms 
The following electronic 
databases will be used: 
 
 
• PsycINFO – approx. 195* 
• PubMed – approx. 97* 
• Web of Science – approx. 577* 
* initially located before de-duplication 
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Appendix B 
SPSS Output – Quality Assessment Interrater Reliability 







Lee et al. (2016) 13 1.00 .00 4.38 p<.001 
Carrico et al. (2019) 13 1.00 .00 5.21 p<.001 
Abed & Shahidi (2019 13 0.72 .19 3.14 p=.002 
Yaghubi & Zargar (2018) 13 0.85 .15 3.79 p<.001 
Lyons et al. (2019) 13 0.73 .18 3.15 p=.002 
Foroushani (2019) 13 0.73 .17 3.32 p=.001 
Chen et al. (2019) 13 0.75 .17 3.81 p<.001 
a. Not assuming the null hypothesis 

































Methodological Quality Rating Scale (MQRS; Miller et al., 1995) 
 
Domain Study Code Study ID.a 
1 2 3 4 5 6 7 
Study 
Design 
1 = Single Group pre-test post-test 
2 = Quasi-experimental (non-equivalent control) 
3 = Randomization with control group 
3 3 3 3 3 3 3 
Replicability 0 = Procedures contain insufficient detail 
1 = Procedures contain sufficient detail 
1 1 1 0 1 1 1 
Baseline 0 = No baseline scores, characteristics or measures reported 1 = Baseline scores, characteristics, or measures reported 
1 1 1 1 1 0 1 
Quality 
Control 
0 = No standardization specified 
1 = Intervention standardization by manual, procedures, 
specific training etc. 
1 1 1 0 1 0 1 
Follow-up 
length 
0 = Less than 6 months 
1 = 6 to 11 months 
2 = 12 months or longer 
0 2 0 0 0 0 2 
Dosage 0 = No discussion of % of treatment received 
1 = % treatment enumerated and accounted for 
0 1 1 0 0 1 0 
Collaterals 0 = No collateral verification 1 = Collaterals interviewed 
0 0 0 0 0 0 0 
Objective 
Verification 
0 = No objective verification 
1 = Verification of records (paper records, blood, materials) 
0 1 1 0 0 1 0 
Dropouts / 
attrition 
0 = Dropouts neither discussed nor accounted for 
1 = Dropouts enumerated and discussed 
0 1 1 1 1 1 1 
Statistical 
Power 
0 = Inadequate power due to sample size / dropouts 
1 = Adequate power with adequate sample size 
0 1 0 1 1 0 1 
Independent 0 = Follow-up nonblind, unspecified 
1 = Follow-up of interventions treatment blind 
0 0 0 0 0 0 1 
Analyses 
0 = No statistical analyses or clearly inappropriate analyses 
1 = Appropriate statistical analyses (group differences, 
characteristics comparable 
1 1 1 1 1 1 1 
Multisite 0 = Single site or comparison of differing intervention 1 = Parallel replications at two or more sites 
0 0 0 0 0 1 0 
Overall risk of bias 7 13 10 7 9 9 12 
 
Study ID. 
1. Lee et al. (2016) 
2. Carrico et al. (2019) 
3. Abed & Shahidi (2019) 
4. Yaghubi & Zargar (2018) 
5. Lyons et al. (2019) 
6. Foroushani (2019) 





































































Participant Information Sheet 
Survey investigating mindfulness in MSM who engage in chemsex 
IRAS Project ID: 279332     REC reference: 20/LO/0986 
IMPORTANT INFORMATION 
Thank you for your interest in this study. My name is Michael Rolt, and I am a Trainee Clinical Psychologist at Royal Holloway, 
University of London (RHUL). RHUL’s Psychology department supports a thriving research culture and, as part of my doctorate, I 
am carrying out an academic research project to explore people’s experiences related to sexualised drug use (‘chemsex’).  
Before you decide whether to take part, it is essential that you fully understand what the study involves. Please take time to 
read the following information carefully. 
 
Purpose of the research 
There is little research about ‘chemsex’ in men who have sex with men (MSM). This project aims to explore the complex factors 
that may be associated with MSM’s engagement in chemsex, including thoughts you may have about yourself and others. It is 
hoped that a better understanding of these factors may contribute to improving future support for MSM. 
 
Why have I been asked to take part? 
This study is open to anyone aged 18 and over, identifies as a man who has sex with men and was has engaged in chemsex 
within the last 12 months. You should also be fluent in English. 
 
What will the study involve? 
If you decide to take part in this study, you will be asked to complete a set of online questionnaires, taking approximately 15 
minutes to complete. You will be asked to enter some demographic information, including your age, gender identity, ethnicity, 
and chemsex experience. You will then be asked to complete several questionnaires explore beliefs, thoughts, and feelings 
about yourself and others. 
 
Consent and voluntary participation 
Your participation in this study is entirely voluntary, and you can stop at any time, without having to provide a reason. At the 
start of the questionnaires, you can create a 7-digit code. If at any time before the end of the project (Feb 2021) you decide to 
withdraw your consent, you can contact me on the email below including the 7-digit code, and I will remove your responses.  
Otherwise, it is assumed that you agree that the terms and conditions of this investigation are clear and that you have 
voluntarily decided to participate in this survey.  
 
What are the incentives in taking part?            
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Whilst there are no immediate therapeutic benefits to taking part in this study, your participation will help advance knowledge 
within this area of psychological research.  
 
Are there any risks in taking part? 
It is unlikely that taking part in this study will harm your psychological well-being. However, you will be required to briefly 
describe difficult or negative experiences and answer questions related to potentially difficult thoughts, feelings, and beliefs. If 
you want to talk to someone about chemsex, please contact the LGBT Foundation: email sexualhealth@lgbt.foundation, or call 
the helpline on 0345 3303030. Further resources can be found at http://lgbt.foundation/chemsex. 
 
Distribution of project results 
At the end of this study, a research report will be given to local support providers (including drug and alcohol services). If you 
would like a copy of the report sent to you directly, you have the option of leaving your email address at the end of the 
questionnaires. Any email addresses will be stored separately from the questionnaire responses and deleted once the report 
has been sent. 
 
Confidentiality 
This survey is anonymous, and IP addresses are not collected. No identifiable information will be collected so that all 
questionnaire responses will be anonymous. Only the research team will have access to the anonymous data collected during 
the study. The findings of this research will be written up as part of my doctoral thesis. It may also be written up and published 
in a scientific journal and presented at scientific conferences. If the study is published, the anonymised data may be made 
available to third parties. Your information will not be identifiable when written up, published or presented. Data from this 
study will be retained for five years following publication in a scientific journal for audit purposes, and subsequently disposed 
of securely. 
 
General Data Protection Information 
Royal Holloway, University of London, is the sponsor for this study and is based in the UK. We will be using information from 
you to undertake this study and will act as the data controller for this study. This means that we are responsible for looking 
after your information and using it properly. Any data you provide during the completion of the survey will be stored securely 
on local servers. Royal Holloway is designated as a public authority. Per the Royal Holloway and Bedford New College Act 1985, 
and the statutes which govern the College, we conduct research for the public benefit and in the public interest. Royal 
Holloway has put in place appropriate technical and organisational security measures to prevent your data from being 
accidentally lost, altered, disclosed, accessed or used in an unauthorised way. Royal Holloway also has procedures in place to 
deal with suspected personal data security breaches. You can find out more about your rights under the GDPR and Data 
Protection Act 2018 by visiting https://www.royalholloway.ac.uk/about-us/more/governance-and-strategy/data-protection/. If 
you wish to exercise your rights, please contact dataprotection@royalholloway.ac.uk. 
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Please feel free to ask any questions you may have before you complete the following consent form. Please email your 
















































Participant Debrief Information Sheet 
Thank you for taking part in the survey.  This is an academic research project conducted by Royal Holloway - University of 
London. The study will result in a research report, which will be given to local support services and providers (including drug 
and alcohol services). All the data collected in this survey will be stored anonymously. 
 
Background: Chemsex drug use amongst men who have sex with men (MSM) in the UK is more prevalent than in the general 
population and can sometimes lead to significant health difficulties. Previous research, among heterosexual populations, has 
found that mindfulness may help improve people's sexual satisfaction by developing better emotion regulation and is 
associated with a reduction in intimacy difficulties. However, it is not known whether these findings are can be applied outside 
of the heterosexual populations studied. 
 
Hypotheses and main questions: This study hopes to extend previous research by exploring the associations between feelings 
of shame and sexual satisfaction with self-efficacy initiating sober sex, and levels of mindfulness in MSM who engage in 
chemsex. Because participants mustn't know the above information before participating, I kindly ask that you do not share this 
information with anyone that may also participate in this study.   
 
Additional support: Whilst we do not anticipate any adverse effects from having taken part within this study, it is possible that 
focusing on difficult experiences, beliefs, thoughts, and/or feelings, may have impacted upon your well-being. If you want to 
talk to someone about chemsex, please contact the LGBT Foundation: email sexualhealth@lgbt.foundation, or call the helpline 
on 0345 3303030. Further resources can be found at http://lgbt.foundation/chemsex. 
 
Further questions? If you have any questions about this study, or you would like to receive a copy of the research findings, 
please do not hesitate to contact me (michael.rolt.2018@live.rhul.ac.uk) or my research supervisor 
(nuno.nodin@live.rhul.ac.uk).  
 





































I have read and understood the information sheet about this study Yes/No 
I have had the opportunity to ask questions, and had any questions answered satisfactorily. Yes/No 
I understand that I am free to withdraw from the study at any time, without giving a reason Yes/No 











































Question Responses (select as appropriate) 
What is your ethnicity? White British Other White European Mixed 
Asian or Asian British Black or Black British Other ethnic Groups 
What is your age?  
What is your gender? Male Non-binary Trans 
Other  
I define my sexuality as… Gay Bisexual Straight 
Pansexual Asexual Other 
My HIV status is… HIV Positive HIV Negative (negative 











































Question Responses (select as appropriate) 
Which of the following have taken 
as part of sexualised drug use? 
G [GHB/GBL] M [M-cat, Mephedrone] T [Tina, Crystal Meth] 
Other  
How often have you engaged in 
chemsex in the last 12 months? 
None Once Two to five times 
Six to ten times Eleven or more times 
Where have you engaged in 
chemsex? 
Chemsex (chill out) 
party 
Cruising area Sex venue (e.g., sauna, 
sex club, dark room 
etc.) 
Home (alone or with 
partner) 
Nightclub or bar  platform 
Chemsex use is impacting my well-
being… 
Positively Negatively No impact 
Unsure  
I feel in control of my chems use? Yes No Unsure 
Have you ever considered support 
related to your chemsex use? 
Yes No Unsure 
During the Coronavirus pandemic 
my chemsex use has… 




































Internalized Shame Scale (ISS; Cook, 1987) 
 
Read each statement carefully and mark the option that indicates 
the frequency with which you find yourself feeling or experiencing 
what is described in the statement; 
Never Seldom Sometimes Frequently Almost 
Always 
I feel like I am never quite good enough.      
I feel somehow left out      
I think that people look down on me.      
All in all, I am inclined to feel that I am a success.      
I scold myself and put myself down.      
I feel insecure about other’s opinions of me.      
Compared to other people, I feel like I, somehow, never measure 
up 
     
I see myself as being very small and insignificant      
I feel I have much to be proud of.      
I feel intensely inadequate and full of self doubt      
I am somehow defective as a person, like there is something wrong 
with me. 
     
When I compare myself to others, I am not as important.      
I have an overpowering fear that my faults will be revealed in front 
of others. 
     
I feel I have a number of good qualities.      
I see myself striving for perfection only to continually fall short.      
I think others are able to see my defects      
I could beat myself over the head with a club when I make a 
mistake 
     
On the whole, I am satisfied with myself.      
I would like to shrink away when I make a mistake      
I replay painful events over and over in my mind until I am 
overwhelmed. 
     
I feel I am a person of worth, at least on an equal plane with 
others. 
     
At times I feel like I will break into a thousand pieces.      
I feel as if I have lost control over my body functions and my 
feelings. 
     
Sometimes I feel no bigger than a pea.      
At times, I feel so exposed that I wish the earth would open up and 
swallow me. 
     
I have this painful gap within me that I have not been able to fill.      
I feel empty and unfulfilled.      
I take a positive attitude toward myself.      
My loneliness is more like emptiness.      








Depression, Anxiety and Stress Scale (DASS-SF; Lovibond & Lovibond, 1995) 
 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the statement applied to you over the 
past week. There are no right or wrong answers. Do not spend too much time on any statement. The rating scale is as follows: 
0 Did not apply to me at all 
1 Applied to me to some degree, or some of the time 
2 Applied to me to a considerable degree or a good part of the time 
3 Applied to me very much or most of the time 
 
Item Question Response 
1 (s) I found it hard to wind down 0 1 2 3 
2 (a) I was aware of dryness of my mouth 0 1 2 3 
3 (d) I couldn’t experience any positive feeling at all 0 1 2 3 
4 (a) I experienced breathing difficulty (e.g. excessively rapid breathing, breathlessness in the absence of physical exertion)  0 1 2 3 
5 (d) I found it hard to work up the initiative to do things 0 1 2 3 
6 (s) I tended to over-react to situations 0 1 2 3 
7 (a) I experienced trembling (e.g. in the hands) 0 1 2 3 
8 (s)  I felt that I was using a lot of nervous energy 0 1 2 3 
9 (a) I was worried about situations in which I might panic 0 1 2 3 
10 (d) I felt that I had nothing to look forward to 0 1 2 3 
11 (s) I found myself getting agitated 0 1 2 3 
12 (s) I found it difficult to relax 0 1 2 3 
13 (d) I felt downhearted and blue 0 1 2 3 
14 (s) I was intolerant of anything that kept me from getting on with what I was doing 0 1 2 3 
15 (a) I felt I was close to panic 0 1 2 3 
16 (d) I was unable to become enthusiastic about anything 0 1 2 3 
17 (d) I felt I wasn’t worth much as a person 0 1 2 3 
18 (s) I felt that I was rather touchy 0 1 2 3 
19 (a) I was aware of the action of my heart in the absence physical exertion (e.g. sense of heart rate increase, heart missing a beat) 0 1 2 3 
20 (a) I felt scared without any good reason 0 1 2 3 


















New Sexual Satisfaction Scale-SF (NSSS-SF; Stulhofer et al., 2011) 
 
For each item, select the option that best reflects your satisfaction with a particular aspect of your sex life in the 
preceding six months, when not using drugs (i.e. sober sex) 
Responses are anchored on the following scale: 
1 = Not at all Satisfied, 2 = A Little Satisfied, 3 = Moderately Satisfied, 4 = Very Satisfied,  
5 = Extremely Satisfied. 
The quality of my orgasms  
My “letting go” and surrender to sexual pleasure during sex  
The way I sexually react to my partner  
My body’s sexual functioning  
My mood after sexual activity  
The pleasure I provide to my partner  
The balance between what I give and receive in sex  
My partner’s emotional opening up during sex  
My partner’s ability to orgasm  
My partner’s sexual creativity  
The variety of my sexual activities  




































Five Facet Mindfulness Questionnaire-SF (FFMQ-SF; Baer et al., 2008) 
 
Below is a collection of statements about your everyday experience. Using the 1-5 scale below, please indicate, in the box to the 
right of each statement, how frequently or infrequently you have had each experience in the last month (or other agreed time 
period). Please answer according to what really reflects your experience rather than what you think your experience should be. 
 




1 2 3 4 5 
I’m good at finding the words to describe my feelings DS  
I can usually put my beliefs, opinions, and experiences into work DS  
I watch my feelings without getting carried away by them NR  
I tell myself that I shouldn’t be feeling the way I’m feeling /NJ  
It’s hard for me to find the words to describe what I’m feeling DS  
I pay attention to physical experiences, such as the wind in my hair or sun on my face OB  
I make judgments about whether my thoughts are good or bad /NJ  
I find it difficult to stay focused on what’s happening in the present moment /AA  
When I have distressing thoughts or images, I don’t let myself be carried away by them NR  
Generally, I pay attention to sounds such as clocks ticking, birds chirping, or cars passing OB  
When I feel something in my body, it’s hard for me to find the right words to describe it /DS  
It seems I am “running automatic” without much awareness of what I’m doing /AA  
When I have distressing thoughts or images, I feel calm soon after NR  
I tell myself I shouldn’t be thinking the way I’m thinking /NJ  
I notice the smells and aromas of things OB  
Even when I’m feeling terribly upset, I can find a way to put it into words DS  
I rush through activities without being really attentive to them /AA  
Usually when I have distressing thoughts or images, I can just notice them without reacting NR  
I think some of my emotions are bad or inappropriate and I shouldn’t feel them /NJ  
I notice visual elements in art or nature, such as colours, shapes, textures, or patterns of light 
and shadows 
OB  
When I have distressing thoughts or images, I just notice them and let them go NR  
I do jobs or tasks automatically without being aware of what I’m doing /AA  
I find myself doing things without paying attention /AA  




Self-Efficacy to initiate in sober sex (SEISS) 
 
Some people find the following situations difficult without using alcohol or drugs. Please rate how confident you 
are of doing the following without needing to use alcohol or drugs. 
Rate your degree of confidence by recording a number from 0 to 100 using the scale given below: 
0 10 20 30 40 50 60 70 80 90 100 
Cannot do at all Highly certain can do 
Without needing to use alcohol or drugs, I would… 
Believe that some people find me sexually attractive  
Feel confident enough to consider having sexual contact with someone  
Be able to make advances towards an existing sexual partner  
Be able to accept advances from an existing sexual partner  
Be able to make advances towards a potentially new sexual partner  








































Approach existing .85 
Accept existing .82 
Approach New .85 
Accept New .87 
a.1 component extracted 



















SPSS Output – Tests of normal distribution 
 
Normality Skewness Kurtosis 
Statistic Std. Error z-score Statistic Std. Error z-score 
Shame .19 .17 .11 -1.06 .33 -3.20 
Nonreactivity -.25 .17 -1.48 .07 .33 .20 
Observe .17 .17 1.00 .40 .33 1.20 
Acting with awareness -.08 .17 -.48 -.41 .33 -1.24 
Describe .21 .17 1.25 .20 .33 .60 
Non-judgment -.08 .17 -.48 -.24 .33 -1.24 
Sexual Satisfaction .173 .17 1.04 -.42 .33 -1.27 
SEISS -.144 .17 -.86 -.72 .33 -2.17 





























SPSS Output – Post-hoc chi-square tests of independence 
   I feel in control of my chems use 
   Yes No Unsure 
Impact of 
chemsex on my 
life 
Positive 
Count 129.0 3.0 4.0 
Expected Count 103.9 16.0 16.0 
Adjusted Residual 8.5 -5.8 -5.3 
p-value <.0001 <.0001 <.0001 
Negative 
Count 9.0 21.0 16.0 
Expected Count 35.2 5.4 5.4 
Adjusted Residual -10.3 8.0 5.5 
p-value <.0001 <.0001 <.0001 
Unsure / No 
impact 
Count 24.0 1.0 5.0 
Expected Count 22.9 3.5 3.5 
Adjusted Residual 0.5 -1.6 0.9 
p-value 0.62 0.11 0.37 
Bonferroni correction: p=.0056 
 
   Considered support related to your chemsex use? 
   Yes No Unsure 
Impact of 
chemsex on my 
life 
Positive 
Count 13.0 121.0 2.0 
Expected Count 36.6 95.6 3.8 
Adjusted Residual -7.6 8.0 -1.6 
p-value <.0001 <.0001 0.11 
Negative 
Count 40.0 4.0 2.0 
Expected Count 12.4 32.3 1.3 
Adjusted Residual 10.4 -10.3 0.7 
p-value <.0001 <.0001 0.48 
Unsure / No 
impact 
Count 40.0 4.0 2.0 
Expected Count 12.4 32.3 1.3 
Adjusted Residual 10.4 -10.3 0.7 
p-value <.0001 <.0001 0.48 





   Considered support related to your chemsex use? 
   Once Two to 
five times 








Count 0.0 24.0 55.0 56.0 
Expected Count 1.3 21.8 46.7 65.3 
Adjusted Residual -1.9 0.9 2.5 -2.7 
p-value 0.06 0.37 0.01 0.01 
Negative 
Count 1.0 3.0 10.0 32.0 
Expected Count 0.4 7.4 15.9 22.2 
Adjusted Residual 1.0 -2.0 -2.1 3.3 
p-value 0.31 0.05 0.04 <.0001 
Unsure / No 
impact 
Count 1.0 7.0 8.0 14.0 
Expected Count 0.3 4.8 10.4 14.5 
Adjusted Residual 1.5 1.2 -1.0 -0.2 
p-value 0.13 0.23 0.32 0.84 




























SPSS Output – Regression assumptions of multicollinearity 
 
 Variable Sexual Satisfaction Self-efficacy initiating sober sex 
Tolerance VIF Tolerance VIF 
Shame .78 1.29 .78 1.29 
Nonreactivity .37 2.67 .37 2.67 
Observe .58 1.72 .58 1.72 
Acting with awareness .74 1.35 .74 1.35 
Describe .58 1.73 .58 1.73 
Non-judgment .38 2.61 .38 2.61 
 
